(AsiaGameHub) - Indonesian online casino users grappling with gambling addiction are turning to increasingly extreme tactics to hide their betting activities. These tactics include creating fake mugging reports, as reported by the Indonesian media outlet Suarakendari. The most recent such incident allegedly occurred in the city of Kendari, Southeast Sulawesi Province, where authorities clarified that a viral social media report about a “violent mugging” had raised alarm. Officers stated the incident involves a 26-year-old man with the initials ME, a resident of Kendari’s Poasia District. The man has “confessed to fabricating the incident out of fear that his wife would scold him for spending his money on online gambling platforms,” police said. Bogus Bandit Report Authorities noted that ME arrived at the Kendari police station on the afternoon of Sunday, March 22, 2026. He told police officers that four unknown individuals had attacked him at 1 p.m. The Kendari Bay Bridge in Kendari, Indonesia. (Image: Government of Indonesia) In his statement to police, ME claimed that two motorcycle riders, each carrying a passenger, had stopped him in the street. He provided detailed descriptions of the attackers and their vehicles, stating they stole a bag and his wallet before fleeing the scene. However, police noted they detected several irregularities and inconsistencies in the victim’s account. “After further investigation, the victim eventually admitted the report was false,” a police spokesperson said. In reality, they found the man’s bag and IDR 2.3 million (around $137) had indeed been stolen, though not in a mugging. Police reported the bag was stolen by thieves at 6 a.m. that same day, while ME was washing his car. But ME said he had exploited the loss to invent a story aimed at covering up his recent unsuccessful $180 online gambling spree. In his statement, ME told police the muggers had escaped with IDR 5.3 million, or $315. Similar cases are increasing in Indonesia. In January, police accused a man in the Arjosari District of Pacitan Regency, East Java, of faking a violent robbery to cover his own online casino losses. The man also shared on social media that he had been beaten and mugged by a gang of highway bandits and filed a complaint with police. He told police the bandits had stolen his money, cut his hand, and made off with his motorcycle. In reality, police said, the man had fabricated the entire story. Officers noted the wound was self-inflicted, and they traced the motorcycle to the man’s friend, who told detectives he had bought the vehicle from the suspect. Addiction Cases on the Rise These developments come as Indonesian doctors issue warnings of sharp increases in the number of inpatients being treated for gambling addiction. Some hospitals report struggling to cope as patient numbers continue to rise steadily. Officials say that at certain times of the year, hospital bed occupancy rates have exceeded 90%. Some prominent psychiatric wards state they are treating hundreds of gambling-addicted patients. Meanwhile, Indonesia’s anti-money laundering agency reports that gambling deposits surged after the Eid al-Fitr holiday period. This marks the second consecutive year the agency has observed such a rise post-Eid. This article is provided by a third-party. AsiaGameHub (https://asiagamehub.com/) makes no warranties regarding its content. AsiaGameHub delivers targeted distribution for iGaming, Casino, and eSports, connecting 3,000+ premium Asian media outlets and 80,000+ specialized influencers across ASEAN.
March Madness: Odds, Predictions, and Picks for Tonight’s St. John’s vs. Duke Sweet 16 Game
(AsiaGameHub) - March Madness is set to continue tonight with four additional Sweet 16 matchups, kicking off with No. 5 St. John’s facing off against No. 1 Duke. Tip-off is scheduled for 7:10 p.m. ET on CBS. DraftKings lists Duke as a 6.5-point favorite with a combined total of 140.5 points as of publication. Sixty-four percent of spread handle and 64% of tickets are backing St. John’s. The Red Storm are a popular underdog bet, but the Blue Devils hold the No. 1 defense in the nation per KenPom. We cashed a winning ticket last night by parlaying the OVER bet for Texas vs. Purdue with Fletcher Loyer scoring at least 15 points. Best Against-the-Spread Pick for St. John’s vs. Duke Blue Devils -6.5 (-108) Duke’s defense is dominant. The Blue Devils stepped up their play in the second half of their Round of 32 matchup against TCU, limiting the Horned Frogs to just 24 total points. Duke advanced to the Sweet 16 without starting point guard Caleb Foster (foot injury), but head coach Jon Scheyer announced he may return to the lineup tonight. Center Patrick Ngongba II returned from his own foot-related absence against TCU, and his presence will be critical tonight in slowing down Zuby Ejiofor in the paint. The Big East Player of the Year averages 16.3 points and 7.3 rebounds per game. Duke’s Cameron Boozer is a frontrunner for the Wooden Award. Boozer leads Duke with averages of 22.4 points, 10.3 rebounds, and 4.2 assists per game. But this game will be won (and covered against the spread) primarily by Duke’s defensive effort. The Blue Devils hold a massive height advantage that will prevent St. John’s from operating effectively near the basket. That level of rim protection will lead to longer-range shot attempts and fewer free-throw opportunities for the Red Storm. Duke also ranks fourth nationally in rebound rate (57.9%), so don’t expect many second-chance scoring opportunities for St. John’s tonight. If the Johnnies hope to find success from beyond the arc, they will face a Duke defense that limits opponents to just 30.5% three-point shooting. That places the Blue Devils 20th in the nation for that defensive metric. Pick: Duke -6.5 Top Player Prop Bet for Duke Blue Devils Patrick Ngongba II OVER 5.5 Rebounds (-108 at FanDuel) Ngongba saw just 13 minutes of play against TCU in his first game back after missing six games due to foot issues. He still managed to pull down four rebounds coming off the bench. Expect his playing time and rebound total to rise tonight against St. John’s, which ranks 147th nationally in field goal percentage at just 45.2%. There will be ample opportunities for him on the defensive glass. Standing at 6-foot-11, Ngongba should have a field day against St. John’s smaller lineup. Top Player Prop Bet for St. John’s Red Storm Dylan Darling UNDER 6.5 Points (-130 at FanDuel) Dylan Darling emerged as a hero with a buzzer-beating game-winner against Kansas, but that was the only basket he scored in that contest. WE HAVE A MARCH BUZZER BEATER WIN FOR THE JOHNIES DYLAN DARLING SENDS ST. JOHNS TO THE SWEET 16 pic.twitter.com/18WNZyP5WP— TNT Sports U.S. (@TNTSportsUS) March 22, 2026 Darling has finished under this prop total in four of his last five games, largely due to his poor three-point shooting. He has gone 1-for-21 from three-point range over that stretch. Given Duke’s elite perimeter defense, it’s difficult to see Darling surpassing this total tonight. This article is provided by a third-party. AsiaGameHub (https://asiagamehub.com/) makes no warranties regarding its content. AsiaGameHub delivers targeted distribution for iGaming, Casino, and eSports, connecting 3,000+ premium Asian media outlets and 80,000+ specialized influencers across ASEAN.
Trio Industrial (1710) 2025 Recorded Revenue at approximately HK$775.3 million; Continues to implement Dual‑engine Strategy of Electronic Manufacturing Services and New Energy Businesses
EQS via SeaPRwire.com / 27/03/2026 / 23:12 UTC+8 【For Immediate release】 Trio Industrial Electronics Group Limited (Stock Code: 1710.HK) Announces 2025 Annual Results* * * Recorded Revenue at approximately HK$775.3 million Continues to implement Dual‑engine Strategy of Electronic Manufacturing Services and New Energy Businesses to Build a “Greater Asia New Energy Business Network” (Hong Kong – 27 March 2026) Trio Industrial Electronics Group Limited (“Trio Industrial” or the “Group”; stock code: 1710), a leading manufacturer and distributor of advanced industrial electronic components and products in Hong Kong, today announced the annual results of the Company and its subsidiaries (the “Group”) for the year ended 31 December 2025 (the “Year”). During the Year, the overall operating environment remained challenging. Europe and North America continued to be the Group’s major markets, where operating conditions were affected by relatively tight interest rate conditions, ongoing geopolitical tensions and the implementation of the revised tariff policy in the United States. In response, many customers adopted a more prudent procurement approach, focusing on inventory management and adjusting their purchasing strategies, which led to weaker demand during the Year. As a result, the Group’s revenue for the financial year 2025 decreased by approximately 23.1% year‑on‑year to approximately HK$775.3 million. Nevertheless, the Group maintained stringent cost control and optimised its staffing and labour structure, resulting in a decrease in overall administrative expenses compared with last year. Overall, the Group recorded a gross profit of approximately HK$139.6 million for the financial year 2025, representing a decrease of approximately 25.5% compared with the previous year, while gross profit margin decreased by 0.6 percentage points from 18.6% to 18.0%. The Group recorded a loss attributable to owners of the Company of approximately HK$35.4 million for the Year. The Group maintained a healthy financial position, with cash and cash equivalents (including restricted bank deposits) of approximately HK$140.5 million and a net cash position (cash and cash equivalents less borrowings). The current ratio was approximately 2.7 times, similar to that as at 30 June 2025 and 31 December 2024. To navigate the complex and evolving global market environment, Trio Industrial is accelerating the implementation of its joint design manufacturing strategy, deepening cooperation with key customers and enhancing value‑add and profit potential from the product design stage, while strengthening long‑term customer relationships. In line with this direction, the Group is actively recruiting professionals who possess both technical expertise and market insights to enhance its global sales and engineering teams, further expand market coverage and support future business growth. In terms of global manufacturing network, the Group’s Thailand production facility serves as a strategic export base for the United States of America and Southeast Asian markets, providing greater flexibility in addressing geopolitical developments and tariff barriers. The Group’s manufacturing facility in the United Kingdom commenced operation in the second quarter of 2025 to serve local customers in Europe and strengthen supply chain security. The Group is also establishing a new manufacturing facility in the United States of America, which is expected to commence operation in the second half of 2026. With a manufacturing network spanning the PRC, Thailand, the United Kingdom and the upcoming facility in the United States of America, the Group is able to offer global customers diversified regional supply assurance and flexibility in response to geopolitical changes and the reshaping of trade patterns. This network not only enhances supply chain resilience, but also underscores the Group’s competitive advantage of “global manufacturing, local services”. In the new energy sector, while optimising the operations of its electronic manufacturing services business, the Group has continued to expand its business from electric vehicle charging manufacturing and charging station operation to include energy storage and distributed energy applications, thereby building an integrated “charging–storage–energy services” business model and further consolidating its position along the new energy value chain. Leveraging the “Belt and Road” Initiative, the Group has established first‑mover platforms in Central Asia and Southeast Asia and is advancing distributed energy storage and e‑mobility projects with regional demonstration effects, injecting new momentum into its medium‑ to long‑term growth. In Kazakhstan, the Group has partnered with Sinooil (a subsidiary of China National Petroleum Corporation) to deploy electric vehicle charging infrastructure and digital advertising facilities at approximately 140 Sinooil petrol stations across the country, creating a scalable platform for the Group’s integrated energy and media business. The Group has established four EV charging stations in Kazakhstan, one of which adopts a “solar‑storage‑charging” configuration, integrating Deltrix EV charging infrastructure, energy storage systems, digital advertising kiosks and intelligent car‑wash facilities. While providing EV charging services, these sites also create a comprehensive ecosystem that combines energy services, digital advertising, automatic car‑wash facilities and convenience retail. This integrated advertising platform is also designed to support Chinese enterprises in expanding into Central Asia and to strengthen the Group’s presence in the regional outdoor media market. Building on this strategic platform in Central Asia, the Group is also expanding its new energy business in Southeast Asia, with the Philippines as the first market in the region. The Group is rolling out Deltrix‑branded electric motorcycles and battery‑swapping projects, offering an integrated “vehicle–battery–cabinet” solution for e‑mobility, which is a typical distributed energy storage application. At the same time, the Group is developing other distributed energy storage solutions for residential, commercial and industrial applications, further broadening its portfolio of new energy products and services in the region. Mr. Cecil Wong, the Chairman of Trio Industrial Electronics Group Limited said, “Despite the continued challenges in the global economic environment, we remain confident in the long‑term trends of industrial electrification, sustainable energy and intelligent development. The Group’s strength lies in combining its expertise in electronic manufacturing with new energy technologies, and in driving business development through a multi‑country manufacturing footprint and technology‑driven execution. Over the next three years, we will focus on business areas with sustainable growth potential, strong technology orientation and clear market demand to further enhance the Group’s earnings quality and cash flow performance.” “At the same time, we will promote deeper integration of artificial intelligence and the Internet of Things to build the ‘Group Intelligent Energy Brain’, using data to drive operational efficiency and transparency in energy management, and ultimately achieve the transformation from a manufacturing enterprise into an intelligent energy ecosystem platform. We believe that by continuously optimising operational efficiency and advancing the integrated development of ‘new energy + new media’, Trio Industrial will further strengthen its competitive advantages amid a rapidly changing market environment, open up high value‑added and sustainable growth opportunities and create long‑term value for shareholders.” - End - About Trio Industrial Electronics Group Limited (Stock Code: 1710.HK) Trio Group is a leading Hong Kong-based manufacturer and supplier of advanced industrial electronic components and products, with over 40 years of industry expertise. Specialising in power supply solutions, the group serves key sectors such as energy efficiency and medical electronics. As the first Hong Kong electronics supplier to achieve Industry 4.0 maturity certificate - industry 4.0 1i level. Trio Group integrates smart manufacturing and innovative technologies to deliver high-performance solutions, earning a strong reputation as a trusted partner for numerous globally recognised brands, primarily in Europe and North America. In response to the growing emphasis on ESG (Environmental, Social, and Governance) principles and the urgent demand for decarbonisation, Trio Group is strategically expanding into the renewable energy sector through its proprietary brand, Deltrix. The company is actively developing solutions in: EV charging infrastructure Solar energy storage systems Smart power management Charging network deployment With a focus on Central Asia and Southeast Asia, Trio Group is committed to advancing green technology innovation, positioning itself as a key player in the global energy transition while driving sustainable business growth. By leveraging its technical expertise and forward-looking strategies, the group continues to reinforce its role in shaping a low-carbon future. This press release is issued by DLK Advisory Limited on behalf of Trio Industrial Electronics Group Limited. For further information, please contact: DLK Advisory 金通策略 Email: pr@dlkadvisory.com Tel: +852 2857 7101 File: 1710_2025AR_press release_EN_20260327_FINAL 27/03/2026 Dissemination of a Financial Press Release, transmitted by EQS News.The issuer is solely responsible for the content of this announcement.Media archive at www.todayir.com
Shoucheng Holdings (0697.HK) Proposes HK$780 Million Dividend: HK$6 Billion in Cumulative Payouts Over Eight Years Solidifies Long-Term Value Logic
HONG KONG, Mar 27, 2026 - (ACN Newswire via SeaPRwire.com) - In the Hong Kong stock market, the key to consistently winning investor trust lies not just in periodic earnings growth, but in the ability to stably transform operating results into shareholder returns. According to the latest 2025 annual results report disclosed by Shoucheng Holdings (0697.HK), the company proposes a dividend of 780 million HKD, corresponding to an average annual market value dividend yield of approximately 5.6%. Looking at the long term, since its strategic transformation in 2018, the company has continuously advanced business transformation and structural optimization, leading to steady improvements in profitability and cash flow quality. It has maintained stable dividends for many consecutive years, with a cumulative dividend scale of approximately 6 billion HKD over eight years, shifting the investment logic from "growth expectations" toward "balancing both growth and returns".It is noteworthy that this dividend does not rely on high leverage or short-term overdrafts; rather, it is a proactive return built on improved balance sheets, enhanced operating quality, and optimized cash flow. As of December 31, 2025, the company's bank balances and cash stood at 3.671 billion HKD, with total borrowings of 979 million HKD. The cash-to-interest-bearing debt coverage ratio is approximately 3.75 times, demonstrating strong dividend sustainability and a significant financial safety margin.Over the past eight years, Shoucheng Holdings has gradually formed a smart infrastructure asset service system centered on parking asset management, industrial space management, REITs investment, and equity investment, constructing a composite model of "operational efficiency + asset management + capital circulation". Mature businesses such as parking and industrial parks continue to provide steady cash flow, serving as the practical foundation for the company's dividends. Meanwhile, REITs investments, the robotics ecosystem, and emerging industry funds further open up space for profit realization and valuation enhancement.Among these, the robotics business is becoming a significant incremental driver of Shoucheng Holdings' long-term value. In recent years, the company has continuously refined its robotics layout around "investment + operations + ecosystem," systematically investing in several leading robotics enterprises. Through scenario integration, channel construction, and industrial services, it has pushed projects from technical verification to commercial implementation. As relevant companies accelerate financing, see valuation increases, or move toward IPOs, the robotics segment is expected to continuously strengthen the company's mid-to-long-term profit release and shareholder return capabilities.Furthermore, in the latest Chairman's Statement, Chairman Zhao Tianyang explicitly expressed "gratitude" to investors and continued to emphasize "creating long-term value for investors". This statement is not merely a declaration of attitude but sends a clear signal: Shoucheng Holdings is placing shareholder returns and long-termism in a more prominent position. For the market, the significance of eight years of continuous dividends has long transcended a simple profit distribution; it serves as a more certain anchor of confidence for long-term capital amidst complex economic cycles. Copyright 2026 ACN Newswire via SeaPRwire.com. All rights reserved. www.acnnewswire.com
Gambling.com announces new CEO appointment amid leadership shakeup following record Q4
(AsiaGameHub) - Gambling.com Group has announced a significant leadership reshuffle, with co-founder and current Chief Operating Officer Kevin McCrystle stepping into the Chief Executive Officer role. McCrystle will succeed fellow co-founder Charles Gillespie, who will transition to the firm’s Executive Chairman position. Slated for mid-May, the transition will conclude Gillespie’s 20-year tenure as CEO— a period during which he guided the company from its 2006 founding to its current status as a publicly traded global business. In that time, Gambling.com has evolved into a technology firm spanning performance marketing and sports data services, operating in more than 20 regulated markets. Michael Quartieri, Lead Independent Director, called Gillespie “one of the longest-serving and most successful CEOs in the history of the online gambling industry”. “Under Charles’ guidance, Gambling.com Group has gone from a mere concept to the first publicly traded online gambling affiliate in the U.S.— now a large, highly profitable global marketing and data services business that has engaged millions of consumers and serves hundreds of online gaming companies,” he said. “As Executive Chairman, Charles’ expertise and direction will still benefit the company— including through his active role in evaluating strategic M&A opportunities and keeping the company at the forefront of the AI revolution. “On behalf of the Board of Directors, we sincerely thank Charles for his 20 years of exceptional service as our first and only CEO, and we look forward to his continued contributions in his role as Executive Chairman.” In his new role as Executive Chairman, Gillespie will stay deeply involved in the company’s strategic direction— including mergers and acquisitions and its ongoing AI focus. McCrystle, who co-founded the company with Gillespie, has served as COO since 2007 and overseen key revenue-driving functions like product, marketing, content, sales and technology. He has also played a pivotal role in the company’s geographic expansion— including building its European operations in Ireland and subsequent growth in the U.S. The board stressed that the leadership change represents continuity rather than a strategic shift, with Quartieri noting Gillespie and McCrystle have worked “in lockstep” since the company’s inception. A new era for Gambling.com The leadership reshuffle comes as Gambling.com enters what it describes as a new growth phase, fueled by the expansion of its sports data services and the increasing role of AI in its operations. In remarks accompanying the announcement, McCrystle highlighted the company’s evolution through multiple stages— from startup to international expansion to public listing— and framed the transition as part of a larger shift toward long-term growth. He explained: “With our fast-growing sports data services business, the ongoing diversification of our marketing business and the power of AI rapidly changing how we operate, it’s clear we are now in a new growth execution phase. “As we continue to implement our strategic initiatives, I am energized to take on the CEO role and lead the entire company with our founder-driven values to best position Gambling.com Group for long-term growth.” The change also comes just weeks after the Nasdaq-listed business released its FY25 results, reporting a year-over-year revenue increase of over 30% to $165.4m (£124.5m). Adjusted EBITDA climbed 19% to $58m, and the business— which now employs hundreds of staff— said it expects 2026 revenues of $170m-$180m, with EBITDA between $50m-$58m. The modest EBITDA growth may have contributed to dampened investor confidence, as Gambling.com’s share price has dropped around 10% since results were released on March 12— falling from $4.35 to $3.93. Despite the leadership shift and stock decline, Gambling.com said its core strategy remains intact, centered on expanding its dual focus on marketing services and sports data. The company operates a portfolio of consumer-facing brands, including Gambling.com, Bookies.com and Casinos.com, alongside data and analytics platforms such as OddsJam, OpticOdds and RotoWire. Leadership remains confident in growth through its brands, and record Q4 revenue of over $35m supports that confidence. On his move from CEO to Executive Chairman, Gillespie added: “I have spent my entire adult life building Gambling.com Group with Kevin, and I look forward to continuing to work closely with him as we enter the next phase of the company’s growth. “As we keep growing our sports data services business, reinvent our marketing business and embrace an AI-driven future, now is the right time to refresh our leadership team and give our most talented leader full reins to drive all parts of the business.” This article is provided by a third-party. AsiaGameHub (https://asiagamehub.com/) makes no warranties regarding its content. AsiaGameHub delivers targeted distribution for iGaming, Casino, and eSports, connecting 3,000+ premium Asian media outlets and 80,000+ specialized influencers across ASEAN.
Lawyers Who Won Against Meta and Google File New Lawsuit Against Sportsbooks
(AsiaGameHub) - Attorneys responsible for a pivotal legal victory against Meta and Google have turned their attention to sports betting operators, filing a new suit against FanDuel and DraftKings in Massachusetts. Jennifer Hoekstra, a partner with the law firm Aylstock, Witkin, Kreis & Overholtz, who contributed to discovery and briefing in the California social media litigation, is spearheading the new action. She is heading a personal injury lawsuit that contends the companies deliberately target at-risk individuals, for instance during late-night hours or following significant losses. “They develop and personalize themselves to the individual user,” Hoekstra informed ESPN. “The algorithm identifies you and your interests when you log in. It appears, making it increasingly addictive for that individual.“ Plaintiff Wagered Millions of Dollars According to the legal filing, the anonymous plaintiff placed bets totaling $3 million on FanDuel from 2023 to 2025. While the exact loss amount is unspecified, the complaint indicates his gambling grew into “an unmanageable addiction to the defendants’ sports betting platforms.” His escalating gambling habit led him to quit his job, and he is currently receiving treatment for addiction. Mirroring another suit filed this week, DraftKings and FanDuel provided him with VIP hosts. In the other case, the two plaintiffs sustained losses exceeding $2 million on the platforms. Hoekstra stated that her new lawsuit concentrates on physical injury, not financial harm. Using Social Media Arguments The core argument that succeeded in the social media lawsuit was that the product was deliberately engineered to be habit-forming. Hoekstra is applying a similar legal strategy against the gambling firms. “We’re claiming that there is an actual physical harm that is being done through the addiction,” Hoekstra explained. “This is what distinguishes our case: the allegation of a defective product that was intentionally and defectively designed to cause this injury.” The suit alleges DraftKings and FanDuel profit from problem gamblers. It references a Connecticut study indicating 51% of sports betting revenue in the state is generated by 2% of players, who are classified as problem gamblers. An earlier lawsuit against DraftKings presented data suggesting 42% of the company’s total revenue originates from roughly 3.8% of its user base. Will ‘Intentionally’ Addictive Argument Work Again? In the Meta case, the plaintiff received $6 million in damages after jurors determined that Meta and Google had intentionally created addictive social media platforms that damaged the 20-year-old's mental health. However, past rulings have found that gambling companies owe no duty of care to compulsive gamblers. Recently, a Pennsylvania judge dismissed a separate lawsuit against DraftKings. In his decision, he stated, “The Court finds that DraftKings has no duty of care to protect Plaintiffs from spending too much money or from developing or fueling a gambling addiction.” Similar to the two new suits, the dismissed complaint claimed that VIP hosts had promoted further losses. The judge determined that the hosts did not control the betting or make decisions for the individuals. “Encouraging them to place bets is insufficient to create a fiduciary relationship,” the judge wrote. A fiduciary relationship is a legal association of trust where one party (the fiduciary) acts for the benefit of another. Because individuals bet voluntarily, the VIP hosts and companies are not held legally accountable. While DraftKings was previously fined $450,000 in Massachusetts for a clear breach of state law regarding credit card deposits, the new lawsuits confront the greater challenge of proving the companies are liable for a gambler's losses. This article is provided by a third-party. AsiaGameHub (https://asiagamehub.com/) makes no warranties regarding its content. AsiaGameHub delivers targeted distribution for iGaming, Casino, and eSports, connecting 3,000+ premium Asian media outlets and 80,000+ specialized influencers across ASEAN.
Raskin and Merkley Propose Legislation to Outlaw Election, War, and Government Prediction Markets
(AsiaGameHub) - Capitol Hill witnessed a flurry of activity surrounding prediction markets on Thursday, as legislative pressure on event contract exchanges reached new heights. Lawmakers unveiled two separate proposals to limit the sector from different regulatory vantage points, including the STOP Corrupt Bets Act.Rep. Jamie Raskin (D-MD) and Sen. Jeff Merkley (D-OR) introduced the bicameral legislation, which takes aim at prediction market contracts linked to elections, military operations, and government actions, marking it as one of the most sweeping proposals directed at the rapidly expanding industry. The measure was introduced on the same day that Sens. Elissa Slotkin (D-MI), Todd Young (R-IN), Adam Schiff (D-CA), and John Curtis (R-UT) put forth separate bipartisan legislation concentrating on insider trading by government officials, illustrating the swift acceleration of efforts to regulate prediction markets in Washington. The simultaneous introduction of these bills indicates that lawmakers are implementing a coordinated, multi-pronged strategy to address prediction markets from various angles rather than pushing a single, unified measure. If this tactic proves successful, it would lead Congress to impose restrictions on an industry that Schiff has dubbed the “Wild West.” Legislation Targets Wagering on Elections, Warfare and Governmental Actions The STOP Corrupt Bets Act is broader in scope than several recent proposals. Rather than adopting a narrow focus on ethics or market integrity, this legislation would prohibit entire categories of event contracts. As drafted, it would modify the Commodity Exchange Act to bar registered entities from listing or trading contracts covering specific “matters described,” including elections, sporting events, and military actions that the bill’s sponsors maintain lack commercial hedging value and essentially operate as unregulated gambling. The measure extends further than other proposals that merely restrict government officials, as it prohibits all individuals from placing such wagers. The legislation expressly bans event contracts on: Political elections or contests Governmental actions taken by the executive, legislative, or judicial branches Sporting events or athletic competitions Military operations conducted by the United States or any foreign nation In the announcement releasing the bill, Raskin stated: “The oligarchs and opportunists are using prediction markets like Kalshi and Polymarket to enrich themselves. By banning bets on elections, legislation, acts of war and other government actions, we can oppose corrupt attempts to rig our democracy and profit from the fix, and we can redeem public faith in the idea that government is an instrument for the common good and not a casino.” The proposed legislation specifically targets event contracts that could be influenced or even known beforehand by government insiders, as well as those that might present a risk to national security. Lawmakers have increasingly expressed concerns that markets related to warfare and geopolitics could create perverse incentives or expose vulnerabilities in the handling of sensitive information. The bill includes a narrow exception for contracts used for “hedging or mitigating commercial risk,” but assigns the Commodity Futures Trading Commission with defining the specific parameters. This measure draws a clear line around which events should be completely prohibited, rather than regulating how participants engage with them, making it one of the most aggressive proposals to date. If enacted, the legislation would require the Government Accountability Office to study the impact of prediction markets on young people, insider trading, and related issues. Legislators Employ Various Tactics as Bills Accumulate The current approach to prediction markets on Capitol Hill could be characterized as a “death by a thousand cuts” strategy. Lawmakers have introduced various bills, many with overlapping objectives and even overlapping sponsors. For example, Sens. Schiff and Curtis are challenging the industry from multiple legal perspectives simultaneously, with both co-sponsoring more than one proposal targeting prediction markets. This layered approach might ensure that if one of the bills fails to gain traction or faces constitutional challenges, another might survive. While some legislation focuses on the ethics of government officials trading on nonpublic information, other bills address regulatory “backdoors” by reclassifying event contracts as traditional sports betting or casino-style gambling. Additionally, Sens. Richard Blumenthal (D-CT) and Andy Kim (D-NJ) have introduced the Prediction Markets Security and Integrity Act, which merges insider trading prohibitions with restrictions on war-related bets and specific consumer protections like age verification and credit card bans. Above all, the multiple measures demonstrate that Congress is committed to eliminating loopholes in the current regulatory framework. This article is provided by a third-party. AsiaGameHub (https://asiagamehub.com/) makes no warranties regarding its content. AsiaGameHub delivers targeted distribution for iGaming, Casino, and eSports, connecting 3,000+ premium Asian media outlets and 80,000+ specialized influencers across ASEAN.
Uni-Bio Science Group Limited Announces 2025 Annual Results
EQS via SeaPRwire.com / 27/03/2026 / 21:31 UTC+8 Record-Breaking Revenue of HK$586.2M and EPS Surged to HK$1.56 Cents Dividends Distributed for Two Consecutive Years Embarks on Innovation-Driven Transformation to Become a Global Pioneer in Regenerative Medicine (27 March 2026 – Hong Kong) A fully integrated biopharmaceutical company – Uni-Bio Science Group Limited (“Uni-Bio Science”, together with its subsidiaries referred to as the “Group”, stock code: 0690.HK), is pleased to announce its annual results for the year ended 31 December 2025 (the “Year”). Key Accomplishments in 2025 During the Year, the Group achieved a spectrum of accomplishments, for both of its marketed products and innovative biologics. The key highlights include: During the Year, the Group delivered record-breaking financial results, with revenue recorded a 6.0% year-on-year (“YoY”) increase, reaching approximately HK$586.2 million. Profit for the year soared by 12.7% YoY to approximately HK$93.3 million, and net profit margin increased by 1.0 percentage points YoY to 15.9%, marking a historic high. The earnings per share reached approximately HK$1.56 cents, reflecting a growth of 15.5% YoY or a CAGR of 18.55% from 2023 to 2025. The Group generated solid cash from operations in the Year, operating cash flow and free cash flow increased by 32.7% and 27.3% YoY, respectively. Cash ratio increased from 0.53 times at the end of 2024 to 1.63 times at the end of 2025. The cash conversion cycle improved from 124 days to 107 days, highlighting greater operating efficiency. Backed by sustainable earnings and a healthy cash flow, the board of directors (“Board”) has declared a dividend payment for 2025 of HK$0.313 cents per share. Since its official launch in March 2024, Bogutai® has sustained strong growth momentum, driven by a solid commercialization strategy and successful academic engagement. In 2025, Bogutai® demonstrated rapid market adoption in China, achieving a remarkable year-on-year revenue growth of 111.0%. In May 2025, the Group’s second ophthalmology product, 金因康® (Diquafosol Sodium Eye Drops), received marketing approval from the China National Medical Products Administration (“NMPA”), marking a significant milestone in expanding the Group’s ophthalmic portfolio following GeneSoft®. The Group is actively preparing its launch and marketing strategy. In addition to leveraging synergy with GeneSoft® and its established online and offline distribution network for rapid market penetration, 金因康® will specifically target the mid-to-high-end segment of dry eye patients outside the hospital setting, those who prioritize long-term efficacy and premium product quality. In June 2025, the Group officially launched the high-end series GeneQueens® of 肌顏態® and the medical device brand 金因敷®, marking two key milestones in its strategic expansion into the integrated“Drug, Medical Device, and Aesthetics”field. These product launches reflect the Group’s commitment to enhancing its skin health product matrix and addressing evolving consumer needs for efficacy-driven, medical-grade skincare in both functional skincare and post-aesthetic recovery. In July 2025, the marketing application of Isavuconazonium sulfate capsules were officially accepted by the NMPA. Isavuconazonium sulfate capsules are expected to be approved for launch as early as the fourth quarter of 2026, offering a safer, more effective, and high-quality treatment option for patients suffering from invasive fungal infections. In 2025, the Group established a strategic partnership with Wenzhou Medical University to explore a thermosensitive gel formulation combining EGF and bFGF, leveraging the university’s proven expertise in bFGF production. As a key growth factor in regenerative medicine, bFGF is highly effective in promoting granulation and angiogenesis. Towards the end of 2025, the Group repositioned its long-term strategy from “Stable Growth” to “Innovation-Driven,” signifying a bold transformation from an integrated pharmaceutical company into a global pioneer in regenerative medicine. The Group is advancing a transformative R&D strategy spanning four key areas: muscular-skeletal regeneration, skin regeneration, ocular regeneration, and ENT regeneration. Annual Results For 2025, the Group recorded a revenue of approximately HK$586.2 million, representing an increase of 6.0% YoY. Revenue from Bogutai® increased from approximately HK$ $63.5 million to approximately HK$ 134.0 million, representing a significant increase of 111.0%. Revenue generated from GeneTime® was approximately HK$220.4 million, representing an increase of 10.9% YoY. GeneSoft® recorded a 7.9% YoY decrease in revenue from approximately HK$41.9 million to approximately HK$38.6 million due to intense market competition. Pinup® recorded a decrease of 29.4% in revenue from approximately HK$244.2 million to approximately HK$172.5 million for the Year. In 2025, the Group adopted a more disciplined and selective hospital-supply strategy under volume-based procurement (VBP) to safeguard margins, particularly in regions where policy adjustments intensified price competition. At the same time, the Group accelerated diversification into pharmacy networks beyond traditional hospital channels and optimized its supply chain to improve cost and profitability. In 2024, Boshutai® was successfully included in the VBP by the Henan Seventeen Provinces Alliance and the procurement validity period is set for two years. Hospitals in many provinces began procuring Boshutai® in 2025. Following the destocking and a low base in 2024, revenue from Boshutai® increased from approximately HK$10.2 million to approximately HK$15.5 million, representing a significant increase of 51.9%. 肌顏態® generated approximately HK$2.8 million in revenue in its early stage. The limited revenue scale reflected several factors, including a relatively small number of products approved and launched during the Year, and the fact that specialized marketing and distribution teams were still being built and optimized. Gross profit was approximately HK$487.6 million, representing an increase of 5.7% as compared with approximately HK$461.1 million in 2024, and gross profit margin increased by 0.2 percentage points YoY to 83.2%. The Group delivered another year of record-breaking profit, achieving approximately HK$93.3 million for the Year, representing an increase of 12.7% YoY. Net profit margin increased by 1.0 percentage points YoY to 15.9%. These results demonstrate the Group’s success in converting product innovation into market value through strong commercialization execution and financial discipline. The earnings per share reached approximately HK$1.56 cents, reflecting a growth of 15.5% YoY. Prospects Regenerative medicine has emerged as a rapidly developing field, focused on repairing, replacing, or regenerating damaged tissues or organs using cells, tissues, or genetic material. The sector has the potential to treat and address the underlying causes of chronic and advanced diseases. The global regenerative medicine market was approximately USD51.7 billion in 2025. It is projected to grow from USD63.0 billion in 2026 to USD555.6 billion by 2034, representing a compound annual growth rate (CAGR) of 31.3%. The increasing prevalence of chronic and hereditary diseases, together with rising healthcare expenditure in both developed and emerging markets, is expected to support continued growth in the regenerative medicine industry. Mr. Kingsley Leung, Chairman of Uni-Bio Science, commented, “In 2025, we are proud to have delivered another year of record profitability, marking a significant milestone in our growth journey. During the year, we entered a new phase of strategic development. In anticipation of an increasingly favorable market environment, we advanced our strategic transition from ‘stable growth’ to ‘innovation-driven’ development, with a clear focus on four diversified therapeutic areas: musculoskeletal regeneration, skin regeneration, ocular regeneration, and ENT regeneration. With multiple products progressing through our pipeline and accelerating toward commercialization, the Group has continued to broaden its marketing channels. In addition to strengthening our established offline hospital networks, deepening partnerships with local distributors, and hosting academic conferences, we have actively expanded into online e-commerce platforms to enhance product accessibility and extend our market reach. Our ambitions extend well beyond China. During the year, we formed a strategic partnership with Kexing Biopharm to accelerate the global expansion of Bogutai®. Through this collaboration, we have granted Kexing Biopharm exclusive commercialization rights for Bogutai® in six international markets—Saudi Arabia, Egypt, Morocco, Colombia, Argentina, and Mexico—laying a solid foundation for global growth. We expect these markets to begin contributing revenue as early as the end of 2026. At the same time, we are advancing the FDA approval process for Bogutai® in the United States, aiming for approval as early as 2027. In December, we also entered into a strategic collaboration with Wenzhou Medical University and the People’s Government of Ouhai District, Wenzhou, to foster a synergistic ‘government–university–enterprise’ model, further strengthening our capabilities in regenerative medicine. Supported by strong partnerships with local governments and leading academic institutions, we are well positioned to build a world-class biomedical ecosystem and enhance our end-to-end innovation capabilities.” About Uni-Bio Science Group Limited Uni-Bio Science Group Limited is an innovative biopharmaceutical enterprise listed on the Main Board of The Stock Exchange of Hong Kong Limited in 2001 (Stock Code: 00690.HK). The Group is committed to powering the advancement of regenerative medicine with next-generation synthetic biology and complex peptide innovation. Focusing on four core research areas—muscular-skeletal regeneration, skin regeneration, ocular regeneration, and ENT regeneration—the Group has built a diversified product pipeline encompassing innovative biologics, high-value generic drugs, and medical aesthetics. The Group operates GMP-compliant production bases in Beijing, Dongguan, and Shenzhen, with fully integrated capabilities spanning R&D, manufacturing, and commercial sales. Uni-Bio Science Group is dedicated to be the global leader in regenerative medicine, redefining how science restores and extends human life. For further information, please contact: ir@uni-bioscience.com 27/03/2026 Dissemination of a Financial Press Release, transmitted by EQS News.The issuer is solely responsible for the content of this announcement.Media archive at www.todayir.com
Swedish Gambling Regulator Appoints New Director General
(AsiaGameHub) - Acknowledging the necessity of navigating a shifting gambling landscape, the Swedish government has named a new Director for Spelinspektionen. Peter Knutsson is set to take charge of Sweden’s gambling sector as the newly appointed Director General of the national gambling authority. Starting August 17, he will replace Johan Röhr, serving a six-year term that concludes in August 2032. Bringing a wealth of experience in political affairs, Knutsson previously held the position of Sweden’s Advertising Ombudsman. Before that role, he served as Head of Unit at the Ministry of Finance. Furthermore, he possesses over 20 years of leadership experience, utilizing his legal background to provide extensive insights into consumer legislation. His professional history includes time at the European Commission and advisory roles for the Swedish Financial Supervisory Authority. Niklas Wykman, the Minister for Financial Markets, congratulated his colleague, emphasizing the importance of bolstering the domestic gambling market with Knutsson’s specific expertise. “The Swedish gambling market should be characterised by high security and strong consumer protection. Spelinspektionen has a major responsibility in this regard,” he stated. “I am pleased that Peter Knutsson, with his deep knowledge of consumer issues, has accepted the role of Director General.” New leadership for a pressured market Knutsson was welcomed by his new colleagues at the regulatory body. Both the Spelinspektionen Board and the outgoing Director expressed their commitment to collaborating with him to improve the Swedish gambling market. Madelaine Tunudd, Chairwoman of the Board, remarked: “With the solid experience Peter Knutsson has from, among other things, the Ministry of Finance, consumer affairs and most recently the Advertising Ombudsman, this will be very good for the authority.” Tunudd recently advanced within Spelinspektionen, ascending from the Vice Chair position she occupied since 2019 to the Chair role following the retirement of her predecessor, Claes Norgren. Meanwhile, Röhr stated his readiness to assist Knutsson as he assumes his new position, aiming to ensure a seamless transition that does not disrupt the regulator’s daily operations. “I welcome the government’s decision on a new Director General for the Swedish Gambling Authority, and will ensure that Peter Knutsson receives a good introduction in my handover as acting Director General,” Röhr concluded. Spelinspektionen has a busy year approaching. A prohibition on credit gambling takes effect on April 1, and later, the regulator will receive enhanced powers to combat offshore operators targeting the Swedish market more effectively. This article is provided by a third-party. AsiaGameHub (https://asiagamehub.com/) makes no warranties regarding its content. AsiaGameHub delivers targeted distribution for iGaming, Casino, and eSports, connecting 3,000+ premium Asian media outlets and 80,000+ specialized influencers across ASEAN.
Bipartisan Senators Propose Public Integrity in Financial Prediction Markets Act
(AsiaGameHub) - The legislative effort against prediction markets pressed forward strongly on Thursday, with lawmakers unveiling yet another bill aimed at the sector. Sens. Elissa Slotkin (D-MI), Todd Young (R-IN), Adam Schiff (D-CA), and John Curtis (R-UT) are spearheading this bipartisan initiative, known as the Public Integrity in Financial Prediction Markets Act of 2026, which seeks to prohibit government officials from leveraging insider information to gain profits from event contracts. As drafted, the legislation aims to stop federally elected officials, political appointees, and government employees from utilizing their access to sensitive, nonpublic information—acquired through their trusted roles—to execute trades on prediction markets. Similar to other proposals, this legislation comes in the wake of multiple reports of alleged insiders securing substantial profits by making suspiciously timely trades ahead of major geopolitical events, including the joint U.S.-Israeli strikes on Iran, where six accounts earned $1.2 million.In a press release announcing the bill, Young referenced these worries: “Public service should never be a pathway to personal profit based on insider information. Recent activity in prediction markets has raised real concerns that individuals with access to sensitive, nonpublic information could exploit that advantage for financial gain.” This measure joins a growing number of bills targeting the industry, as lawmakers from both parties voice concerns over insider trading, sports contracts, and markets linked to war and government actions. Bill Covers Congress, Executive Branch Staff & Political Appointees The proposed bill aims to address what many view as an ethics gap, as prediction markets are being used more frequently as financial tools, sparking worries about insider trading. Under the legislation, “covered individuals” would encompass the president, vice president, members of Congress, and employees of executive or independent regulatory agencies. Those in these categories would be prohibited from using:“Material nonpublic information that a reasonable investor would deem significant when making a decision about a prediction market contract and that is not publicly accessible.” The bill would establish strict penalties and reporting requirements: Authorizes fines of $500 or double the profit from the trade, whichever is higher. Oversight ethics offices are required to establish regulations, issue guidance, and collect reports on transactions exceeding $250. Any covered individual involved in a transaction worth over $250 must submit a detailed report to their oversight ethics office within 30 days. Slotkin stressed why she believed the bill is needed: “No one should profit from the information and knowledge gained through public service, plain and simple. This bill is a crucial initial step in establishing commonsense regulations for prediction markets, with real enforcement to ensure those who violate these rules face tangible consequences. I’m proud of our bipartisan group and thank Senators Young, Schiff, and Curtis for collaborating with me to advance this critical legislation.” Curtis noted that the bill would apply long-standing insider-trading principles to a new form of financial product. Schiff, on the other hand, contended that the industry cannot be left to regulate itself. Competitive Field of Prediction Market Legislation The Public Integrity in Financial Prediction Markets Act enters an already packed arena of legislative proposals competing for attention on Capitol Hill, as members of Congress aim to define their stances in the debate. In January, Rep. Ritchie Torres (D-NY) introduced a House version of the same act. On the same day Slotkin, Young, Schiff, and Curtis introduced this bill, Sen. Jeff Merkley (D-OR) and Rep. Jamie Raskin (D-MD) unveiled the STOP Corrupt Bets Act, a bicameral bill that would prohibit prediction market betting on elections, government actions, and military operations. Other recent proposals include the End Prediction Market Corruption Act by Merkley and Sen. Amy Klobuchar (D-MN), Schiff’s DEATH BETS Act, and the Prediction Markets Security and Integrity Act of 2026 by Sens. Richard Blumenthal (D-CT) and Andy Kim (D-NJ). Other bills advancing through Congress include the Prediction Markets Are Gambling Act by Sens. John Curtis (R-UT) and Adam Schiff (D-CA), and the PREDICT Act by Reps. Adrian Smith (R-NE) and Nikki Budzinski (D-IL), which focuses on political event contracts. Considering the number of bills under consideration in Congress, one thing is clear: Congress is seeking to address what it perceives as the prediction market issue from various perspectives. Though no single bill has yet distinguished itself, it appears lawmakers have no plans to ease the pressure on prediction markets in the near future. This article is provided by a third-party. AsiaGameHub (https://asiagamehub.com/) makes no warranties regarding its content. AsiaGameHub delivers targeted distribution for iGaming, Casino, and eSports, connecting 3,000+ premium Asian media outlets and 80,000+ specialized influencers across ASEAN.
Government Provides Transition Grants to Support Gambling Charities
(AsiaGameHub) - The British government is working to alleviate the financial strain on charities addressing gambling harm as they navigate a new, and at times contentious, funding system. According to the Department for Culture, Media and Sport (DCMS), which oversees gambling regulation in the UK, the statutory research, education, and treatment (RET) levy has generated nearly £120 million in its inaugural year. This substantial amount is earmarked specifically for research into, prevention of, and treatment for gambling-related harm. However, the transition from the previous funding arrangements to the new model has posed difficulties for some charitable organizations. To address these challenges, the DCMS has established a three-month transition grant fund. This grant will be accessible to UK charities focused on gambling harm from April 1 to June 1, 2026. In instances where the DCMS makes a decision after April 1, charities will be permitted to submit claims retroactively. Charities will be required to meet specific eligibility criteria to be considered for a grant. Eligible organizations must have been engaged in 'relevant activity' in March 2026 to support service users in England. Furthermore, they must have previously applied for and been unsuccessful in securing funding from the gambling levy through either the Gambling Harms Prevention VCSE Grant Fund or the Gambling Harms Treatment VCSE Grant Fund. The purpose of this grant is to cover staffing costs and associated overheads necessary for the continued operation of charity services. Capital expenditures, defined as any spending that results in the creation or improvement of an asset valued at over £2,000, are not eligible for funding. Organizations have until April 30, 2026, to submit their grant applications. Charities navigate a controversial shift The levy was a key component of the Gambling Act review, replacing the former system where operators voluntarily contributed 1% of their revenue to GambleAware. GambleAware then managed the commissioning of RET projects nationwide. Invoices for the statutory levy were first issued by the UK Gambling Commission (UKGC) on September 1, 2025, with a payment deadline of October 1, 2025. The levy is now an annual obligation for licensed operators, with invoices dispatched on September 1 each year. However, the introduction of the levy has not been without controversy, and several charities have expressed concerns regarding the long-term viability of the UK's gambling harm research, education, and treatment system under the new funding structure. NHS England, which is undergoing restructuring, has assumed responsibility for treatment funding. The Office for Health Improvement and Disparities (OHID) will oversee prevention efforts, and UK Research and Innovation (UKRI) will manage research initiatives. GambleAware ceased operations earlier this month, as its commissioning functions have been effectively transferred to the NHS. The charity had long advocated for the establishment of a statutory levy, but with itself retaining the lead role in commissioning. Various charitable organizations voiced alarm at these changes when the Gambling Act review White Paper was published in April 2023, and have continued to do so. For instance, the Gambling Lived Experience Network (GLEN) shared some frustrations on LinkedIn just last week. However, the organization did offer some commendation for OHID, describing its performance as significantly better than that of NHS England and UKRI. Is there any going back? Regardless of the opinions held by charities, it appears that the statutory levy is a permanent fixture. Even if the government were to reconsider its position, such a significant undertaking would require considerable time to reverse. The process of commissioning services is also well underway. In Scotland, the devolved government has begun allocating its £7.9 million share of the UK-wide gambling levy. These funds will be distributed among the NHS, local authority partners, and the third sector, which includes charities. Scotland's Public Health Minister, Jenni Minto, stated: “Gambling harm is a significant issue affecting far too many people in Scotland. It impacts not only individuals who gamble but also their families, relationships, communities, and society as a whole. “We are already working diligently with partners to mitigate this, and these awards represent a major step forward. This funding will support a variety of projects and programs for individuals dealing with what is often an unseen issue. “Data indicates that over two percent of Scottish adults – more than 90,000 individuals – may be problem gamblers. The funding provides a balanced approach across the third sector, including community and voluntary organizations, and services delivered through the NHS and local authorities.” The largest beneficiaries include the RCA Trust (£1 million), Public Health Scotland (£967,000), NHS Greater Glasgow and Clyde (£926,000), Fast Forward (£561,000), Citizens Advice Scotland (£450,000), and Simon Community Scotland (£445,000). Other recipients are Gambling With Lives (£124,000), Charity Space Scotland (£47,000), Scottish Ambulance Service (£45,000), Young Scot (£30,000), and Dundee and Angus College (£52,000). The RCA Trust, the largest recipient, offers counseling services for individuals affected by gambling-related harm and other conditions such as drug and alcohol abuse. Andy Todd, a spokesperson for the charity, commented: “The funding provided by the Scottish Government will be crucial for the ongoing delivery of prevention, education, training, treatment, and support for those impacted by gambling harms across Scotland. “With gambling harms now being addressed through a public health model, we look forward to collaborating with partners to reduce harms by expanding service provision, decreasing stigma, and working with lived experience perspectives to integrate policy and practice among frontline staff.” The distribution of gambling harm treatment funding in Scotland follows the Welsh government's announcement of how its share of the RET levy funds would be allocated nine months prior. However, there is still no confirmation regarding how funds will be utilized in England. Overall, the government anticipates raising between £90 million and £100 million annually from the levy. According to the DCMS, this target was exceeded in its first year, yet there remains no clarity on how these funds will be spent in England, the UK's largest nation. This article is provided by a third-party. AsiaGameHub (https://asiagamehub.com/) makes no warranties regarding its content. AsiaGameHub delivers targeted distribution for iGaming, Casino, and eSports, connecting 3,000+ premium Asian media outlets and 80,000+ specialized influencers across ASEAN.
Playtech CEO targets global growth opportunities as company seeks to regain momentum
(AsiaGameHub) - Live casino products provide limitless opportunities for operators in the U.S., as stated by Mor Weizer, Chief Executive Officer of Playtech, during an interview with SBC News. Shortly after Playtech released its full-year 2025 results, Weizer told us that the Group will stay focused on expanding the live casino market in the U.S., even though the product has lower adoption rates than in many other global regions. “We see the U.S. as a huge opportunity,” he noted. “Live casinos are indeed very popular in Asia, and they’re also well-received in some other markets—there are countries where live casino makes up 25-30% of total gaming activity. “In the U.S., as you rightly noted, adoption rates are still limited to around 17%. However, we see this as a chance because we are confident that the U.S. market’s fundamentals will enable significant growth in live casino. “As we stated earlier today, live casino customers generate 1.8 times more revenue than regular casino players, which creates a cross-selling opportunity for operators to expand live casino offerings in the U.S. further.” A Global Shield Against Tax Burdens The Americas region overall has been a critical contributor to Playtech’s financial performance over the past year, particularly as the company undergoes a rapid transition to a B2B-focused business. However, a notable point from the FY25 report was that B2B costs rose while B2B revenue declined year-over-year (YoY). When asked if Playtech can reverse this trend in 2026, Chris McGinnis, Chief Financial Officer, noted that revenue was affected by the updated agreement with Caliente International, but costs are projected to increase at a slower pace this year, and profits are expected to return to growth alongside this. Looking ahead, this year is set to bring higher tax burdens in several of Playtech’s key markets, including Brazil and the UK. Nevertheless, the company’s management is confident that Playtech can weather these challenges due to its diversified portfolio. McGinnis explained: “The most significant impact for Playtech has been in the UK, where the government announced an increase in the Remote Gaming Duty. We issued a statement indicating that this would have a major effect on our business. “But we remain optimistic. Playtech is geographically diversified, so even with tax hikes in the UK and other regions, we are still confident that we will continue to grow.” Weizer further emphasized: “We have a strong presence in other markets such as Italy, Spain, France, Poland, Romania, and the Scandinavian region. This broad diversification means we are well-equipped to handle any regulatory changes that may arise.” Finally, Playtech confirmed that it is exploring several new markets to boost its diversification, specifically Finland, New Zealand, and Ireland. All three nations are currently implementing major regulatory changes. Finland is working to end its state-run gambling monopoly with operator Veikkaus by June 2027, New Zealand is set to launch its first online gambling licenses, and Ireland has a new gambling regulator that will reshape the country’s domestic market. Weizer concluded: “Finland is adopting a new regulatory framework that will allow operators to enter the market openly. We view this as a chance to deepen our partnership with Veikkaus. “We also have existing Scandinavian partners who are eager to enter the Finnish market as soon as the regulatory changes take effect. “New Zealand, meanwhile, is currently unregulated but is considering introducing regulations. Playtech is seeking to partner with operators that are likely to establish themselves there, including both B2B partners and structured agreement partners. “As for Ireland, they are also revising their regulatory framework. We see this as an opportunity due to our strong connections with individuals who have access to the Irish market.” This article is provided by a third-party. AsiaGameHub (https://asiagamehub.com/) makes no warranties regarding its content. AsiaGameHub delivers targeted distribution for iGaming, Casino, and eSports, connecting 3,000+ premium Asian media outlets and 80,000+ specialized influencers across ASEAN.
Sports Betting and Gaming Companies Expand Sponsorships Across Diverse Sports
(AsiaGameHub) - Despite ongoing discussions about marketing budget reductions, sports sponsorship activity within the global betting and gaming sector shows no signs of deceleration. The past fortnight has seen a new surge of agreements spanning motorsport, football, baseball and sports data. This Sponsor Spotlight examines the worldwide platform of Formula 1, explores various football agreements throughout Europe, and ventures across the Atlantic to identify which iGaming operators are establishing a presence in the US market and their specific locations. Allwyn races to the forefront of Formula 1 Following a successful inaugural season, Formula 1 has prolonged its collaboration with Allwyn via a new multi-year contract. The agreement capitalises on Formula 1's sustained international expansion, with the sport now reaching 827 million supporters and a total television viewership of 1.8 billion. The refreshed partnership prioritises enhancing fan interaction through digital and interactive initiatives. A significant enhancement involves Allwyn's incorporation into the F1 Predict platform, enabling fans to predict race results through the newly created "Allwyn League", with rewards including grand prix tickets and Paddock Club entry. The brand will also achieve greater exposure during formation laps, representing one of the most prominent segments of a race weekend. This development follows a momentous period for the UK's National Lottery operator, encompassing the release of its financial results, finalisation of its OPAP merger, and exceeding the £450 million investment threshold for National Lottery modernisation. Tipico scores in the nation of its headquarters Tipico Group has entered into a multi-year contract with the Malta Football Association, securing status as an official partner of the national squad. Departing from conventional sponsorship models, this arrangement focuses on employer brand development, specifically promoting Tipico's recruitment platform and drawing local expertise in technology, finance and business positions. The collaboration encompasses branding on team kits, stadium promotions and digital media, all designed to boost recognition among Malta's labour pool and reinforce Tipico's standing as a permanent employer in what has become a favoured location for iGaming companies. PureWager goes in to bat for Baltimore Orioles PureWager Group has entered the US professional sports arena via a sponsorship agreement with the Baltimore Orioles. This designation establishes PureWager as the sole sports betting partner of the baseball organisation and involves establishing the PureWager Pavilion at Oriole Park, Camden Yards, conceived as a communal area for supporters. The deal coincides with PureWager's preparations to debut its wagering and online casino platform in the United States, with intentions to expand into numerous states after an initial launch in Michigan. Eurobet.live taps into ‘second screen’ trend with AS Roma Eurobet.live has secured a multi-year sponsorship with AS Roma, assuming the role of the club's principal shirt sponsor until the 2028/29 campaign. The collaboration is notable for its emphasis on infotainment over conventional sportsbook marketing, seeking to comply with Italy's stringent advertising restrictions. Eurobet.live will assume a pivotal function in AS Roma's digital content approach, generating matchday material, interviews and social media elements. The agreement targets the "second screen" demographic – supporters who interact with statistics and content whilst viewing matches. Veikkaus sponsor capitalises on a Scandinavian niche Finnish National Lottery operator Veikkaus Oy has been appointed principal partner of this year's men's Floorball World Championships, hosted in Finland. Finland's men's team enters the competition as defending world champions, having secured the title in Sweden during 2024. The sport has surged in popularity throughout Scandinavia, with final weekend tickets already exhausted, as Veikkaus seeks to leverage this momentum through sponsorship and broaden brand recognition before significant industry reforms in Finland. Spotlight rankings: Who’s standing out? 1: Formula 1 / Allwyn Viewed globally, this partnership is particularly prominent. Combining Formula 1's extensive reach with Allwyn's expanding sporting footprint, it unites two substantial organisations on a worldwide platform. Both entities have also experienced recent international expansion. 2: PureWager / Baltimore Orioles Entering the US sports market via an MLB franchise provides PureWager with a robust foundation for establishing brand recognition before a broader rollout. 3: Eurobet.live / AS Roma Italy's wagering market ranks as Europe's second-largest, and the revised regulatory structure has been well received. Gaining exposure through a prominent Serie A club represents a shrewd strategic decision. 4: Tipico / MFA While Malta stands among the globe's most significant gambling centres, its domestic market remains relatively modest by European standards due to the country's limited population. Nevertheless, preserving positive relationships with local sporting partners is always advisable. 5: Veikkaus Oy / Floorball Finally, Veikkaus' most recent sponsorship initiative does not match the scope of other agreements examined here. Nonetheless, it aligns perfectly with the company's reputation as a socially conscious operator, potentially offering significant advantages when Finland liberalises its market to additional licensees in 2027. This article is provided by a third-party. AsiaGameHub (https://asiagamehub.com/) makes no warranties regarding its content. AsiaGameHub delivers targeted distribution for iGaming, Casino, and eSports, connecting 3,000+ premium Asian media outlets and 80,000+ specialized influencers across ASEAN.
Xunce Technology’s Revenue Surges 449% Half-on-Half: Is a Structural Revaluation to a Hundred-Billion Market Cap Camp on the Horizon?
HONG KONG, Mar 27, 2026 - (ACN Newswire via SeaPRwire.com) - As AI accelerates into the inference era, enterprise-grade AI is achieving large-scale deployment, driving an exponential surge in Token consumption and ushering data demand into a new development stage. Against this backdrop, high-quality, structured and scenario-specific professional data has become critical for enterprises to forge core strategic competitiveness in the era of AI.As a leading provider of AI real-time data infrastructure and analysis services in China, Xunce Technology is rapidly solidifying its core position in AI data, driven by industry tailwinds, full-chain technological capabilities and diversified growth engines. Amid the unfolding landscape of the intelligent economy, this ten-year industry stalwart is entering a pivotal window for structural revaluation.Token Value Restructuring: Making Every Data Access Quantifiable and MonetizableFounded in 2016, Xunce Technology has built a full-chain technological system spanning data acquisition, cleansing, standardization, real-time computing and large- model optimization over a decade of development. With AI Data Agent at its core, the Company specializes in millisecond-level real-time data processing, serving a diversified portfolio of industries including finance, urban governance, high-end manufacturing, healthcare, robotics, satellite applications, low-altitude economy, electric power, power grids and energy.As the era of AI inference unfolds, Token is evolving from mere “fuel” to a form of “hard currency”. Maximizing the value of each individual Token has emerged as a central challenge in the large-model inference era. Today, general-purpose large models typically rely on a “computing power for precision” approach, where every inference run generates substantial wasteful Token consumption. Should inference fail, all Tokens expended in the process are lost entirely, which is a common pain-point plaguing general AI systems.By contrast, vertical AI solutions equip general large language models with an external industry “brain” powered by domain-specific data. At its core, such solutions optimize inference logic via business-aware models, enabling upfront task feasibility validation and eliminating Token waste at the source. With deep expertise in professional vertical domain data modeling, Xunce Technology leverages its extensive portfolio of high-quality, scenario-specific proprietary data to act as an “efficiency multiplier” for every Token invocation. This structure translates Token consumption into higher-precision outputs while securing maximal result certainty. Crucially, the Company is developing full-chain capabilities spanning data metering, pricing and settlement, enabling quantifiable and monetizable measurement for every data access. By elevating per-unit Token efficiency, it delivers enhanced business value to enterprise clients.Aligned with this strategy, Xunce’s platform features a “LEGO-inspired” modular architecture, enabling clients to flexibly compose modules tailored to their specific needs. This “assemble-on-demand, adapt-in-real-time” design fosters deep and long-term customer stickiness. The Company also employs a highly flexible pricing framework, with fees structured around module count, processing throughput and other key metrics. Supported by subscription, transaction-based and Token-based payment models, its pricing mechanism precisely aligns with diverse client demands.Currently, Xunce Technology is fully building a full-chain data measurement and settlement system. It is exploring pricing mechanisms tied to large model inference frequency and module usage count, allowing customers to pay for effective Tokens rather than raw computing power consumption.Inflection Point Reached, Profitability ConfirmedDriven by Token value restructuring and innovative business models, Xunce Technology has delivered robust performance and reached a historic inflection point. In H2 2025, the Company posted an adjusted net profit of RMB 50 million, achieving its first positive profitability. Meanwhile, revenue rose from RMB 197.85 million in H1 2025 to RMB 1,086.81 million in H2, representing a 449.32% quarter-on-quarter surge. Amid rapid business expansion, the Company has witnessed a substantial improvement in profitability.Explosive Revenue GrowthReturn to Profit in H2Doubled ARPU & Per Capita GrowthImproved Cash Flow & Operating Metrics+103% Y/YNarrowed by 33%+105% Y/YSignificant Improvement2025 full-year revenue YoY growth2025 full-year adjusted net loss2025 ARPU YoY growth2025 net operating cash flow+449% H/HRMB 50 million+135% Y/YAmple cash on hand in 20252025 H2 revenue HoH growth2025 H2 adjusted net profit2025 per capita revenue YoY growthAverage collection period decreased in 2025For the full year, the Company posted total operating revenue of RMB 1,284.66 million, representing a substantial year-on-year increase of 103.28% and successfully breaking the key milestone of RMB 1 billion in revenue. This signifies that the Company has evolved from an early-stage, technology-driven startup into a new era of platform-based development with scalable and replicable business models.Furthermore, the Company’s combined gross proceeds for 2025 amounted to approximately RMB 792.08 million, representing a substantial increase of 63.44% compared to approximately RMB 484.63 million in the previous year. In terms of adjusted net loss, after deducting one-off non-recurring gains and losses, the Company’s adjusted net loss for 2025 was RMB 54.84 million, representing a significant narrowing of 33% from RMB 82.37 million in 2024.Notably, the Company achieved combined gross margin of 62% in 2025, exceeding that of Cambricon (55%), a leading AI chip provider, and far outpacing general large- model developer Minimax (25.4%). This underscores its high-value strategic positioning and resilient business model in the AI data infrastructure sector.In terms of R&D investment, Xunce Technology has also maintained efficient growth conversion. In 2025, the Company’s R&D expenditure reached RMB 450.44 million, with R&D expenses accounting for 48% of revenue, driving a 105% year-on-year increase in operating revenue. For comparison, Minimax’s R&D expenditure accounted for as high as 219% of its revenue, with a revenue growth rate of 159%. Xunce achieved a comparable expansion pace with a lower R&D intensity.As revenue scale continues to expand and gross margin in new industries gradually stabilize, the Company’s short-term objective is to achieve an inflection point in adjusted net profit. Looking ahead, as the industries already deployed enter a period of margin stabilization and Token-based payment and revenue-sharing models gain accelerated traction, its net profit is poised to improve at an accelerated rate.Driven by Diversified Growth Engines, Business Structure Continuously OptimizedThe robust revenue growth is not accidental, but underpinned by Xunce Technology’s multi-dimensional, systematically structured growth framework.Accelerate cross-industry replication. The Company currently covers 9 major industries, benchmarking Palantir’s 17 industries and leaving ample room for horizontal expansion. Xunce Technology is rapidly deepening its presence in key national strategic sectors such as asset management, telecommunications, electric power, urban management, high-end manufacturing, healthcare, energy, robotics training platforms and commercial aerospace. For each new industry, the Company first completes industry-specific data accumulation over 3 to 5 years, enabling rapid replication and scaled deployment across peer customers thereafter.The business model fosters deep customer value enhancement. As customers evolve from single-module adoption to multi-module deployment, and from pilot trials to full integration into core business workflows, substantial upside potential in ARPU remains. By synergistically lifting Token invocation volume, module usage count and per-Token value, the Company will unlock a new dimension of growth.Steadily expand overseas business and establish a global layout. The Company targets raising its overseas revenue share to 10% to 15% in 2026, and will further escalate its globalization strategy during 2027 and 2028, unlocking new avenues for sustained long-term growth.Cultivate a strategic cooperative ecosystem to forge deep integration with upstream and downstream partners in computing power and algorithms. Xunce Technology is engaging in in-depth collaboration with leading domestic GPU providers and large language model enterprises to build a one-stop solution encompassing “infrastructure computing power, upper-layer applications and data governance,” further solidifying its core position in the AI data infrastructure sector. Pioneer cutting-edge applications to seize commanding heights in future industries. From robotics data platforms to commercial aerospace, low-altitude economy and power grid systems, Xunce Technology has taken the lead in extending AI infrastructure to emerging sectors with stringent demands for real-time performance and operational reliability. Such mission-critical scenarios with ultra-high requirements for data timeliness and stability serve as a rigorous validation of the Company’s technological advantages. The Company will continue to ramp up R&D investment in frontier fields, refine its technical capabilities through high-end application scenarios and unlock new high-growth, high-value growth tracks for long-term development.Evolving from Data Services to Core AI Economy Infrastructure: Building Sustainable Competitive BarriersFrom a macro perspective, the artificial intelligence data sector is witnessing a profound convergence of five defining trends: a surge in demand for real-time, secure, high-quality data in the era of AI Agent; the rise of domain-specific models elevating professional data as a critical enabler for industry-wide intelligent upgrading; standardization of data interfaces driven by next-generation AI operating systems including Open Claw, positioning Xunce Technology as a core data Token provider; Token-based payment emerging as a new paradigm for the data element market; and the implementation of data asset capitalization policies, spurring a sharp rise in enterprises’ mandatory investment in data governance.At the intersection of these five pivotal trends, Xunce Technology has established a robust fundamental logic for sustained long-term growth. The Company has evolved beyond a traditional data infrastructure provider to become a critical “connector” and “enabler” linking large models, computing power and cloud vendors. By integrating upstream models, downstream computing power and horizontal collaboration with cloud vendors, the Company delivers irreplaceable data-centric value to its enterprise clients.The Company stresses that it shares a natural upstream-downstream synergy with general large-model providers, rather than a competitive dynamic. Analogous to the deep collaboration between GPU manufacturers and model developers, the value of Xunce Technology lies in a mutually reinforcing cycle: the wider the adoption of models by its clients, the greater the opportunity for the Company to deliver services and generate incremental value for clients.Notably, in contrast to niche market players offering only isolated modules such as data cleansing or computing engines, Xunce Technology’s core differentiation lies in its full-process coverage and outcome-driven accountability. The Company provides an end-to-end solution spanning data acquisition, cleansing, standardization, modeling, real-time computing and model tuning, ensuring that final data delivered to clients is clean, accurate, real-time and accessible for model invocation at millisecond latency. Furthermore, through deep integration into clients’ private clouds or on-premises environments, the Company acts as a dedicated data steward, fostering exceptional customer stickiness and forging robust, sustainable competitive barriers.Currently, the Company’s product portfolio and solutions feature more than 300 functional modules, covering a full spectrum of scenarios from data infrastructure to upper-layer analytics applications. In 2025, its active paid clients base reached 230, with an outstanding customer retention rate of 90%. ARPU increased substantially from RMB 2.72 million in 2024 to RMB 5.59 million in 2025, representing a year-on-year growth of over 103%.As algorithms become increasingly open-source and computing power tends toward standardization, what truly sets companies apart lies in data — particularly industry data that has undergone sophisticated governance and can effectively empower large models. Backed by a decade of deep industry expertise, Xunce Technology has established a substantial and sustainable competitive barrier in this domain.ConclusionFrom an early-stage private equity tool provider to a cross-industry AI data infrastructure builder, and from a module supplier to a Token-priced core platform, Xunce Technology has remained committed to unlocking data as a scarce, strategic resource that is freely circulable, readily callable and empowered to drive high-quality decision-making.Amid the rapid emergence of new intelligent economic paradigms, the Company stands at the threshold of a fundamental structural revaluation, with the potential to enter the RMB 100-billion market cap camp. It is a competitor to none, but an indispensable partner to all. Copyright 2026 ACN Newswire via SeaPRwire.com. All rights reserved. www.acnnewswire.com
Application Submitted for LENVIMA(R) (lenvatinib) in Japan Seeking Approval of Additional Dosage and Administration for Combination with WELIREG(R) (belzutifan) for Renal Cell Carcinoma that has Progressed After Chemotherapy
TOKYO, Mar 27, 2026 - (JCN Newswire via SeaPRwire.com) - Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, “Eisai”) and MSD K.K. (Headquarters: Tokyo, Representative Director: Prashant Nikam, “MSD”), a subsidiary of Merck & Co., Inc., Rahway, NJ, USA, announced today that an application for LENVIMA® (lenvatinib), an orally available multiple receptor tyrosine kinase inhibitor (TKI) discovered by Eisai, has been submitted in Japan for the additional dosage and administration in combination with WELIREG® (belzutifan), the first-in-class oral hypoxiainducible factor-2 alpha (HIF-2α) inhibitor from MSD, for the treatment of unresectable or metastatic renal cell carcinoma that has progressed after chemotherapy.This application is based on the results of the Phase 3 LITESPARK-011 trial evaluating the dual regimen of LENVIMA plus WELIREG for the treatment of patients with advanced renal cell carcinoma (RCC) whose disease progressed on or after treatment with anti-programmed death receptor-1 (PD-1)/ programmed death-ligand 1 (PD-L1) therapy. The data from this trial were presented at the 2026 American Society of Clinical Oncology (ASCO) Genitourinary (GU) Cancers Symposium in February 2026. At a pre-specified interim analysis with a median follow-up of 29.0 months (range, 19.3-49.2), the LENVIMA plus WELIREG combination therapy demonstrated a statistically significant and clinically meaningful improvement in progression-free survival (PFS), one of the primary endpoints, reducing the risk of disease progression or death by 30% (HR=0.70 [95% CI, 0.59-0.84]; p=0.00007) compared to cabozantinib. The safety profile of this combination was consistent with those reported for each agent administered as monotherapy, and no new safety signals were identified.In 2022, approximately 435,000 people worldwide were newly diagnosed with kidney cancer, and about 156,000 people died from the disease. 1 In Japan, it is estimated that roughly 21,000 people were newly diagnosed and about 7,000 died in 2022.2 RCC accounts for approximately 85% of kidney cancers3, and the five-year survival rates for patients with stage III and IV RCC have been reported as 63%–78% and 27%–28%4, respectively, indicating that the disease still has a high unmet medical needs.LENVIMA is approved in combination with KEYTRUDA ® (pembrolizumab) in Japan for the first-line treatment of unresectable or metastatic RCC. WELIREG is approved in Japan for the treatment of unresectable or metastatic RCC that has progressed following cancer chemotherapy. Additionally, supplemental New Drug Applications (sNDA) for the LENVIMA and WELIREG combination therapy for the treatment of adult patients with advanced RCC with a clear cell component following a PD-1 or PDL1 inhibitor has been accepted by the U.S. Food and Drug Administration (FDA), with a PDUFA (Prescription Drug User Fee Act) target action date set for October 4, 2026.Eisai and MSD have been collaborating through the provision of information on LENVIMA in Japan since October 2018, and will work together to expedite the maximization of contribution to patients with cancer.About LENVIMA (lenvatinib)LENVIMA, discovered and developed by Eisai, is an orally available multiple receptor tyrosine kinase inhibitor that inhibits the kinase activities of vascular endothelial growth factor (VEGF) receptors VEGFR1 (FLT1), VEGFR2 (KDR), and VEGFR3 (FLT4). LENVIMA inhibits other kinases that have been implicated in pathogenic angiogenesis, tumor growth, and cancer progression in addition to their normal cellular functions, including fibroblast growth factor (FGF) receptors FGFR1- 4, the platelet derived growth factor receptor alpha (PDGFRα), KIT, and RET. In syngeneic mouse tumor models, LENVIMA decreased tumor-associated macrophages, increased activated cytotoxic T cells, and demonstrated greater antitumor activity in combination with an anti-PD-1 monoclonal antibody compared to either treatment alone. LENVIMA has been approved for the indications below.Thyroid cancer- Indication as monotherapy(Approved mainly in Japan, the United States, Europe, China and Asia)Japan: Unresectable thyroid cancerThe United States: The treatment of patients with locally recurrent or metastatic, progressive, radioiodine-refractory differentiated thyroid cancer (DTC)Europe: The treatment of adult patients with progressive, locally advanced or metastatic, differentiated (papillary/follicular/Hürthle cell) thyroid carcinoma (DTC), refractory to radioactive iodine (RAI)Hepatocellular carcinoma- Indication as monotherapy(Approved mainly in Japan, the United States, Europe, China and Asia)Japan: Unresectable hepatocellular carcinomaThe United States: The first-line treatment of patients with unresectable hepatocellular carcinoma (HCC)Europe: The treatment of adult patients with advanced or unresectable hepatocellular carcinoma (HCC) who have received no prior systemic therapy- Indication in combination with KEYTRUDA (generic name: pembrolizumab) and transarterial chemoembolization (Approved in China)Thymic carcinoma- Indication as monotherapy (Approved in Japan)Japan: Unresectable thymic carcinomaRenal cell carcinoma (In Europe other than the United Kingdom, the agent was launched under the brand name Kisplyx®)- Indication in combination with everolimus(Approved mainly in the United States, Europe and Asia) The United States: The treatment of adult patients with advanced renal cell carcinoma (RCC) following one prior anti-angiogenic therapyEurope: The treatment of adult patients with advanced renal cell carcinoma following one prior vascular endothelial growth factor (VEGF) targeted therapy- Indication in combination with KEYTRUDA(Approved mainly in Japan, the United States, Europe and Asia)Japan: Radically unresectable or metastatic renal cell carcinomaThe United States: The first-line treatment of adult patients with advanced renal cell carcinomaEurope: The first-line treatment of adult patients with advanced renal cell carcinomaEndometrial carcinoma- Indication in combination with KEYTRUDA(Approved mainly in Japan, the United States, Europe and Asia)Japan: Unresectable, advanced or recurrent endometrial carcinoma that progressed after cancer chemotherapyThe United States: The treatment of patients with advanced endometrial carcinoma that is pMMR or not microsatellite instability-high (MSI-H), as determined by an FDA-approved test, who have disease progression following prior systemic therapy in any setting and are not candidates for curative surgery or radiationEurope: The treatment of adult patients with advanced or recurrent endometrial carcinoma (EC) who have disease progression on or following prior treatment with a platinum-containing therapy in any setting and are not candidates for curative surgery.About WELIREG (belzutifan)WELIREG, Merck & Co., Inc., Rahway, NJ, USA’s, known as MSD outside of the United States and Canada, first-in-class hypoxia-inducible factor 2 alpha (HIF-2α) inhibitor, is an orally administered small-molecule designed to reduce transcription and expression of HIF-2α target genes associated with cellular proliferation, angiogenesis and tumor growth. By inhibiting HIF-2α signaling, WELIREG aims to disrupt key pathways certain tumors may use to adapt to low-oxygen conditions, including those that help promote abnormal blood vessel formation and support tumor survival. WELIREG has demonstrated antitumor activity in certain von Hippel-Lindau (VHL) diseaseassociated tumors, renal cell carcinoma and in pheochromocytoma or paraganglioma. As part of a broader clinical program, Merck & Co., Inc., Rahway, NJ, USA continues to research WELIREG monotherapy and combination approaches for people with genitourinary, breast and gynecologic cancers across a range of treatment settings to further define where HIF-2α inhibition may provide clinical benefit and to better understand which patients are most likely to respond. WELIREG has been approved in Japan for the treatment of certain von Hippel–Lindau (VHL) disease–associated tumors, as well as for unresectable or metastatic renal cell carcinoma that has progressed after chemotherapy.LITESPARK-011 ResultsData from LITESPARK-011 (ClinicalTrials.gov, NCT04586231) were presented at the ASCO GU Symposium held in February 2026. LITESPARK-011 is a randomized, open-label Phase 3 trial (ClinicalTrials.gov, NCT04586231) evaluating WELIREG in combination with LENVIMA compared to cabozantinib for the treatment of patients with advanced clear cell RCC that has progressed on or after anti-PD-1/L1 therapy. The dual primary endpoints are progression-free survival (PFS) per Response Evaluation Criteria in Solid Tumors version 1.1 (RECIST v1.1) as assessed by blinded independent central review (BICR), and overall survival (OS). Secondary endpoints include objective response rate (ORR) per RECIST v1.1 as assessed by BICR, duration of response (DOR) per RECIST v1.1 as assessed by BICR, and safety. The trial enrolled 747 patients who were randomized to receive WELIREG (120 mg orally once daily) plus LENVIMA (20 mg orally once daily) or cabozantinib (60 mg orally once daily).At a pre-specified second interim analysis with a median follow-up of 29.0 months (range, 19.3- 49.2), WELIREG plus LENVIMA demonstrated a statistically significant and clinically meaningful improvement in the primary endpoint of PFS, reducing the risk of disease progression or death by 30% (HR=0.70 [95% CI, 0.59-0.84]; p=0.00007) compared to cabozantinib. For WELIREG plus LENVIMA, the median PFS was 14.8 months (95% CI, 11.2-16.6) versus 10.7 months (95% CI, 9.2-11.1) for cabozantinib. A trend toward improvement in overall survival (OS), the trial’s other primary endpoint, was also observed for WELIREG plus LENVIMA (HR=0.85 [95% CI, 0.68-1.05]; p=0.06075). The median OS was 34.9 months (95% CI, 27.5-NR) for WELIREG plus LENVIMA versus 27.6 months (95% CI, 24.0-31.4) for cabozantinib. The trial is continuing, and OS will be evaluated at a subsequent analysis per the clinical trial protocol. Regarding secondary endpoints, at the first interim analysis with a median follow-up of 19.6 months (range, 9.9-39.8), WELIREG plus LENVIMA met ORR, demonstrating a statistically significant improvement compared to cabozantinib. A confirmed ORR of 52.6% (95% CI, 47.3-57.7) was observed for WELIREG plus LENVIMA versus 39.6% (95% CI, 34.6-44.8) for cabozantinib. At the second interim analysis with a median follow-up of 29.0 months, the median DOR was 23.0 months (95% CI, 2.0-44.3+) for WELIREG plus LENVIMA versus 12.3 months (95% CI, 1.8+-35.9+) for cabozantinib. WELIREG plus LENVIMA was administered to 370 patients and cabozantinib was administered to 371 patients. Grade ≥3 treatment-related adverse events (TRAEs) occurred in 71.6% of patients receiving WELIREG plus LENVIMA versus 65.8% of patients receiving cabozantinib. Adverse events led to treatment discontinuation in 11.1% of patients receiving WELIREG plus LENVIMA and in 11.3% of patients receiving cabozantinib, respectively. Serious adverse events were observed in 51.6% of patients receiving WELIREG plus LENVIMA versus 43.9% of patients receiving cabozantinib, and AEs led to death in 5.4% of patients (two were treatment-related: thrombotic microangiopathy [n=1] and pneumonitis [n=1]) versus 3.2% (one was treatment-related: hemoptysis [n=1]) of patients, respectively.About the Eisai and Merck & Co., Inc., Rahway, NJ, USA Strategic CollaborationIn March 2018, Eisai and Merck & Co., Inc., Rahway, NJ, USA through an affiliate, entered into a strategic collaboration for the worldwide co-development and co-commercialization of LENVIMA. Under the agreement, the companies jointly develop, manufacture and commercialize LENVIMA, both as monotherapy and in combination with Merck & Co., Inc., Rahway, NJ, USA’s anti-PD-1 therapy, KEYTRUDA, and HIF-2α inhibitor, WELIREG.Eisai’s focus on cancerEisai acknowledges “Oncology” as one of its key strategic areas, and will continue to focus on the discovery and development of anti-cancer drugs within drug discovery domains including “microenvironment”, “protein integrity and homeostasis”, and “cell lineage and cell differentiation” under the Deep Human Biology Learning (DHBL) drug discovery and development organization. Eisai aspires to discover innovative new drugs with new targets and mechanisms of action from these domains, with the aim of contributing to the cure of cancers.6. About EisaiEisai’s Corporate Concept is “to give first thought to patients and people in the daily living domain, and to increase the benefits that health care provides.” Under this Concept [also known as our human health care (hhc) Concept], we aim to effectively achieve social good in the form of relieving anxiety over health and reducing health disparities. With a global network of R&D facilities, manufacturing sites and marketing subsidiaries, we strive to create and deliver innovative products to target diseases with high unmet medical needs, with a particular focus in our strategic areas of Neurology and Oncology.In addition, our continued commitment to the elimination of neglected tropical diseases (NTDs), which is a target (3.3) of the United Nations Sustainable Development Goals (SDGs), is demonstrated by our work on various activities together with global partners. For more information about Eisai, please visit www.eisai.com (for global headquarters: Eisai Co., Ltd.), us.eisai.com (for U.S. headquarters: Eisai Inc.) or www.eisai.eu (for Europe, Middle East, Africa, Russia, Australia, and New Zealand headquarters: Eisai Europe Ltd.), and connect with us on X (U.S. and global), LinkedIn (for U.S. and EMEA) and Facebook (global).Merck & Co., Inc., Rahway, NJ, USA’s Focus on CancerEvery day, we follow the science as we work to discover innovations that can help patients, no matter what stage of cancer they have. As a leading oncology company, we are pursuing research where scientific opportunity and medical need converge, underpinned by our diverse pipeline of more than 25 novel mechanisms. With one of the largest clinical development programs across more than 30 tumor types, we strive to advance breakthrough science that will shape the future of oncology. By addressing barriers to clinical trial participation, screening and treatment, we work with urgency to reduce disparities and help ensure patients have access to high-quality cancer care. Our unwavering commitment is what will bring us closer to our goal of bringing life to more patients with cancer. For more information, visit https://www.merck.com/research/oncologyAbout MSDAt MSD (the name by which Merck & Co., Inc., Rahway, NJ, USA, is known outside of the United States and Canada), we are unified around our purpose: We use the power of leading-edge science to save and improve lives around the world. For more than 130 years, we have brought hope to humanity through the development of important medicines and vaccines. We aspire to be the premier research-intensive biopharmaceutical company in the world – and today, we are at the forefront of research to deliver innovative health solutions that advance the prevention and treatment of diseases in people and animals. We foster a diverse and inclusive global workforce and operate responsibly every day to enable a safe, sustainable and healthy future for all people and communities. For more information, visit www.msd.co.jp and connect with us on Facebook, Twitter, and YouTube.Ferlay J, Ervik M, Lam F, Laversanne M, Colombet M, Mery L, et al. (2024) Global Cancer Observatory: Cancer Today. Lyon, France: International Agency for Research on Cancer. Available from: https://gco.iarc.who.int/media/globocan/factsheets/cancers/29-kidney-fact-sheet.pdf, accessed 27 Mar 2026.Ferlay J, Ervik M, Lam F, Laversanne M, Colombet M, Mery L, et al. (2024) Global Cancer Observatory: Cancer Today. Lyon, France: International Agency for Research on Cancer, Available from: https://gco.iarc.who.int/media/globocan/factsheets/populations/392-japan-fact-sheet.pdf, accessed 27 Mar 2026.National Comprehensive Cancer Network. NCCN Clinical Practice Guidelines in Oncology: Kidney Cancer. 2025; 2026 Version 1. Rose TL and Kim WY. Renal cell carcinoma: a review. JAMA. 2024 Sep 24;332(12):1001– 10.Media InquiriesEisai Co., Ltd.Public Relations DepartmentTEL: +81 (0)3-3817-5120MSD K.K.Communications DivisionTatsuro MuraseTEL: +81 (0)70-8700-0112 Copyright 2026 JCN Newswire via SeaPRwire.com. All rights reserved. www.jcnnewswire.com
Hitachi and MUFG Bank expand NextGen model to finance vehicles and charging infrastructure for decarbonized mobility
TOKYO, Mar 27, 2026 - (JCN Newswire via SeaPRwire.com) - Hitachi, Ltd. (TSE: 6501, “Hitachi”) and MUFG Bank, Ltd. (“MUFG Bank”), a consolidated subsidiary of Mitsubishi UFJ Financial Group, Inc. (TYO: 8306, “MUFG”) today announced a new Memorandum of Understanding (MoU) to expand NextGen, their business co-creation model. Building on their collaboration launched in May 2024*1 and further developed as announced in May 2025*2 , NextGen combines Hitachi’s technology and operational expertise with MUFG’s financial capabilities to accelerate the transition to decarbonized mobility.*1 MUFG’s Business Co-Creation and Investment into UK Battery as a Service project by Hitachi ZeroCarbon May 2024*2 Hitachi ZeroCarbon and MUFG unite technology expertise with financial support to accelerate fleet electrification May 2025NextGen was initially validated through a UK pilot project with First Bus, where the parties collaborated via a special purpose vehicle (SPV) to support the procurement and operation of electrification assets under a Battery-as-a-Service model. This expanded MoU extends NextGen beyond battery-focused structures, enabling broader and more scalable deployment across additional markets outside the UK and across a wider range of asset classes. These include emobility assets such as electric vehicles and charging infrastructure, associated energy management systems, and potentially extending to energy hubs supporting industrial assets, power grids and data centers.Hitachi and MUFG Bank will also develop and scale SPV structures to finance decarbonized mobility assets for fleet and transport operators. This approach removes capital constraints and accelerates implementation, enabling operators to focus on their core transport services. From Hitachi’s side, the initiative is led by its Strategic SIB Business Unit, bringing together expertise from across Hitachi including Hitachi Energy, as ‘One Hitachi’. Hitachi will also provide managed services for asset performance and lifecycle optimization, supported by data-driven solutions from Hitachi ZeroCarbon. Through this initiative, Hitachi aims to further advance and streamline mobility and charging infrastructure operations by expanding HMAX by Hitachi, a suite of next-generation solutions that embodies Lumada 3.0, differentiated by deep domain knowledge and AI.Electrifying commercial transport at pace will require an unprecedented deployment of vehicles, charging and energy infrastructure - alongside innovative financing models to support it. Global investment in electrified transport reached around US$750 billion in 2024, making it the largest segment of the energy transition worldwide*3 - yet many fleet operators face limited access to capital and the operational complexity of transitioning at scale. Against this backdrop, Hitachi and MUFG Bank aim to expand NextGen as a repeatable model to accelerate implementation by combining structured asset financing with managed services and data-driven optimization.*3 Sources: BloombergNEF’s Energy transition Investment Trends 2025In demonstration of the expanded pipeline, Hitachi ZeroCarbon and MUFG Bank have also entered into an MoU with Boreal Norge AS and its subsidiary Boreal Buss AS, one of Norway’s primary transport operators, providing transport services across several counties and employing around 3,000 employees across its fleet, which includes over 850 buses and 35 ferries. The parties will explore how they can support Boreal’s transition planning, de-risk operations, optimize services and strengthen competitiveness as concessions evolve.Jun Taniguchi, Senior Vice President and Executive Officer, CEO of Strategic SIB Business Unit, at Hitachi, Ltd. said:“We are delighted to advance this partnership which combines Hitachi’s deep expertise in social infrastructure and digital technologies with MUFG Bank, Ltd.’s financial strength to accelerate the transition to a decarbonized society. By improving the performance of assets such as batteries and charging infrastructure through Hitachi’s digital services led by HMAX, we can truly help customers optimize the total cost of ownership. This partnership embodies our One Hitachi approach, leveraging our diverse capabilities across the Group to support our customers in achieving their net-zero ambitions.”Masakazu Osawa, Senior Managing Executive Officer Chief Executive, Japanese Corporate & Investment Banking Business Unit of MUFG Bank, Ltd., said:“Building on MUFG’s Business Co‑Creation and Investment approach, this collaboration with Hitachi aims to create value through strategic partnerships that improve society and the environment. For the global EV market, our focus is not only on strengthening Hitachi’s leading position in Battery as a Service, but also on fostering a holistic value chain — including second‑ life battery markets — that supports the acceleration of electric mobility and the achievement of 2050 net‑zero targets. Together with our partners, we are committed to co‑creating sustainable businesses that become a driving force for progress worldwide.”Nikolai Knudsmoen Utheim, Group CEO, Boreal Norge AS said:“Our priority has always been to deliver first-class transport services to our customers, whether that’s on the road, rail or over water. In exploring how we can unlock the power of electrified fleets, we can not only deliver more sustainable operations, but upgrade our infrastructure and thread technology across our entire business model for more efficient, smart transport and energy management.”About Hitachi, Ltd.Through its Social Innovation Business (SIB) that brings together IT, OT (Operational Technology) and products, Hitachi contributes to a harmonized society where the environment, wellbeing, and economic growth are in balance. Hitachi operates globally in four sectors – Digital Systems & Services, Energy, Mobility, and Connective Industries – and the Strategic SIB Business Unit for new growth businesses. With Lumada at its core, Hitachi generates value from integrating data, technology and domain knowledge to solve customer and social challenges. Revenues for FY2024 (ended March 31, 2025) totaled 9,783.3 billion yen, with 618 consolidated subsidiaries and approximately 280,000 employees worldwide. Visit us at www.hitachi.com.About MUFGMitsubishi UFJ Financial Group, Inc. (MUFG) is one of the world’s leading financial groups. Headquartered in Tokyo and with over 360 years of history, MUFG has a global network with approximately 2,000 locations in more than 40 countries. The Group has about 150,000 employees and offers services including commercial banking, trust banking, securities, credit cards, consumer finance, asset management, and leasing. The Group aims to “be the world’s most trusted financial group” through close collaboration among our operating companies and flexibly respond to all of the financial needs of our customers, serving society, and fostering shared and sustainable growth for a better world. MUFG’s shares trade on the Tokyo, Nagoya, and New York stock exchanges. For more information, visit https://www.mufg.jp/english.About BorealBoreal is a leading mobility provider, operating buses, fast ferries, passenger ferries and trams in Norway and Sweden. We remain firmly committed to our societal mission of encouraging more people to travel collectively. At the same time, we are more than public transport. As the only company operating buses, ferries, fast ferries, trams and tourism services, we deliver integrated mobility solutions and travel experiences. Although Boreal is a young company in name, its heritage extends back more than 150 years. The company has around 3,000 employees and is headquartered in Stavanger, Norway. Copyright 2026 JCN Newswire via SeaPRwire.com. All rights reserved. www.jcnnewswire.com
Analogue 2025 Annual Results Profit Attributable to Owners of the Company Increases 23.5% to HK$167.0 Million
HONG KONG, Mar 27, 2026 - (ACN Newswire via SeaPRwire.com) - Analogue Holdings Limited (“Analogue” or the “Company”, together with its subsidiaries, the “Group”) (stock code: 1977), a leading provider of electrical and mechanical (“E&M”) engineering solutions, and information and communications technology services for smart cities, today announced its annual results for the year ended 31 December 2025 (“the Year” or “FY2025”) with net profit growth, contracts-in-hand achieving another record high and order intake more than doubled, providing a solid business foundation for the coming three years and beyond.Financial Highlights- Profit attributable to owners of the Company increased 23.5% to HK$167.0 million.- Contracts-in-hand surged 61.8% to HK$17,878.7 million, hitting another record-high, made possible by a 113.7% increase in order intake to HK$12,913.6 million during the Year.- The intake of new maintenance contracts for housing programmes, environmental projects and lifts and escalators increased 51.4% to HK$1,669 million, reinforcing the recurring revenue stream.- The Group maintained a strong cash position, with bank balances and cash of HK$1,020.8 million and gearing ratio reduced to 10.1% for FY2025 from 26.2%.- The Board has resolved to pay a second interim dividend of HK2.9 cents per share. Total dividend for the year amounted to HK5.5 cents per share with 25.6% increment year-on-year.Chairman Dr Mak Kin Wah said, “The Year 2025 saw profound changes around the world, with challenges and yet also opportunities. Our Group has continued to stride forward: upholding what we commit by delivering the fundamentals well, striving for continuous improvement to make transformation actionable, investing in technology advancement and productivity, and bringing Hong Kong’s engineering excellence to the world. We are pleased to report that the Group achieved profit growth, secured a record level of contracts-in-hand, and continued to build on our international market presence. These accomplishments highlight our distinctive comprehensive capability across diverse business segments, our commitment to excellence, and our leadership in advanced engineering techniques.”“Supported by strong cashflow, we are in a strong position to take on additional work where appropriate and to seize high-value opportunities as they arise. We will continue to stay agile and focused on capturing opportunities across our broad portfolio, build on our competitive strengths through continuous improvement, and reinforce the use of innovative solutions that enhance quality, safety and performance. We remain steadfast in our commitment to our customers, recognising that this is fundamental to earning their trust and cultivating enduring, strategic partnerships. Guided by our motto – ‘We Commit. We Perform. We Deliver’ – we will continue to maximise value for customers, shareholders, suppliers and stakeholders, while contributing to the communities we serve.”Business Review: Building Services- This segment remains the largest revenue contributor, with revenue reaching HK$3,279 million.- Contracts-in-hand reached a record-high level of HK$8,297 million with the total value of new contracts secured in FY2025 doubled to HK$6,470 million. The Group’s competitive edge in multidisciplinary packaged projects and its industry leadership in innovative MiMEP and other new engineering techniques helped it to secure major contracts.- With strategic investments to accelerate innovation and modern manufacturing facilities in Zhuhai and Hong Kong, the Group continues to lead in MiMEP and DfMA technologies.- Following the successful acquisition of a property management licence, the Group expanded its business to deliver integrated solutions across the entire building lifecycle. This new capability, spanning construction, maintenance, operations and long-term facility management, creates a potential revenue stream that complements core services.- Through continuous development of innovative technologies and operational optimisation, the segment is positioning itself to maintain the market competitiveness while exploring opportunities in other markets in Southeast Asia.Environmental Engineering- This segment achieved record-high contracts-in-hand and order intake, increasing 86.9% and 253.7% to HK$8,094 million and HK$5,355 million respectively. Segment revenue also increased by 18.0% year-on-year to HK$1,591 million.- The segment maintained active tendering throughout the period and was awarded significant contracts, including contracts of a record-breaking value to relocate sewage treatment works in Sha Tin to caverns, sewage pumping station at Ma On Shan and more.- Formed a joint venture company in Qingyang city to explore the operation and maintenance business in the Chinese Mainland.- Explored project opportunities in Asia and the Middle East and the expansion of its expert services into Europe.Information, Communications and Building Technologies (“ICBT”)- Segment revenue remained at HK$630 million. Contracts-in-hand totalled HK$852 million at the year end, and order intake was HK$523 million during the Year.- This segment continued to reinforce its leadership in green and intelligent building solutions under the DigiFusion brand, to enable the development of smarter, more sustainable urban environments.- Continued to leverage ATAL Tower as a platform for developing innovative technologies and broaden its technological capabilities through strategic collaborations with leading manufacturers in the Chinese Mainland and around the world, to strengthen its ability to deliver scalable, high-performance solutions across a wide range of sectors.Lifts and Escalators- Revenue and order intake increased 11.0% to HK$587 million and by 3.2% to HK$566 million respectively.- Transel Elevator & Electric Inc. (TEI), the associate company in the United States (US), secured a contract for the world-class vertical transportation system in the iconic 56-storey luxury hotel skyscraper on the border of Times Square in New York. TEI also further strengthened its market position by extending its footprint into the Southeastern part of US.- Actively built on its presence in the UK and broadened its network across other international markets, reinforcing its global ambitions in vertical transportation solutions.- Machine-Room-Less lift products continued to gain traction in key international markets- Streamlined the manufacturing processes of Nanjing factory, broadened its product portfolio and strengthened the overall product quality, aligning with the Group’s global vision and reaffirming its commitment to delivering reliable, high-performance vertical transportation solutions.For further details of the 2025 Annual Results, please refer to the announcement filed with The Stock Exchange of Hong Kong Limited.About Analogue Holdings LimitedEstablished in 1977, Analogue Holdings Limited is a leading provider of electrical and mechanical (“E&M”) engineering solutions and information and communications technology (“ICT”) services for smart cities, with headquarters in Hong Kong and operations in the Chinese Mainland, Macau, the United States, the United Kingdom, Germany, Singapore and Malaysia. Serving a wide spectrum of customers from public and private sectors, the Group provides multidisciplinary and comprehensive E&M engineering and technology services in four major segments, including Building Services, Environmental Engineering, Information, Communications and Building Technologies (“ICBT”) and Lifts & Escalators.The Group also manufactures and sells lifts and escalators internationally and has entered into an alliance with Transel Elevator & Electric Inc. (“TEI”), one of the largest independent lifts and escalators companies in New York, the United States. The Group’s associate partner, Nanjing Canatal Data-Centre Environmental Tech Co., Ltd. (603912.SS), specialises in manufacturing of precision air conditioners. Copyright 2026 ACN Newswire via SeaPRwire.com. All rights reserved. www.acnnewswire.com
Behind the 449% Sequential Revenue Growth: Xunce Technology, Accelerates Its Embrace of the Token Economy
EQS via SeaPRwire.com / 27/03/2026 / 18:36 UTC+8 On March 27, 2026, Hong Kong-listed Xunce Technology (03317.HK) released its 2025 annual results, delivering a standout performance that captured market attention. The company achieved full-year revenue of RMB 1.285 billion, representing year-on-year growth of 103.28%, crossing the RMB 1 billion revenue threshold. Adjusted net loss narrowed to RMB 54.85 million, a significant improvement of 33.31% from the previous year. More importantly, the company achieved adjusted net profit of RMB 50.13 million in the second half of 2025, marking its first semi‑annual profitability and confirming a clear inflection point. In terms of growth trajectory, first‑half revenue was RMB 198 million, while second‑half revenue surged to RMB 1.087 billion, a 449.32% sequential increase. This explosive growth closely aligns with the concentrated release of enterprise demand for real‑time data as AI models entered a phase of large‑scale deployment. As the AI industry shifts its focus from "model training" to "inference at scale," the strategic importance of data infrastructure is being fundamentally rewritten. Behind these results lies Xunce Technology's value realization as a core player in AI‑driven real‑time data infrastructure, signaling the arrival of a new era driven by the token economy. Financial Inflection Point: More Than Growth – A Qualitative Shift What makes Xunce's 2025 results particularly compelling is not just the revenue growth, but the simultaneous improvement in profitability and growth trajectory. The shift in profitability carries even greater significance. Full‑year adjusted net loss narrowed to RMB 54.85 million, a 33.41% improvement over 2024. Looking at the second half alone, the company achieved adjusted net profit of RMB 50.14 million – a sharp reversal from the RMB 105 million loss in the first half – marking its first semi‑annual profit. This demonstrates that the company's business model has successfully navigated the transition from scale expansion to profit generation. From a financial structure perspective, as of the end of 2025, total assets reached RMB 3.172 billion, net assets stood at RMB 2.42 billion, and cash and cash equivalents reached RMB 1.084 billion, an increase of approximately 216% year‑on‑year, providing ample "ammunition" for future strategic investments. The asset‑liability ratio was only 1.51%, reflecting minimal leverage and a very solid financial foundation. In terms of operational efficiency, revenue per employee jumped from RMB 1.22 million in 2024 to RMB 2.87 million, an increase of 135.25%, effectively doubling workforce productivity. Customer ARPU also increased from RMB 2.72 million to RMB 5.59 million, up 105.04% year‑on‑year, demonstrating a growing ability to deepen value from each client. Based on these metrics, Guotai Haitong Securities expects the company to achieve full‑year profitability in 2026. Token‑Based Pricing: From Selling Tools to Value Sharing With the arrival of the token era, the role of tokens is undergoing a fundamental shift – they are no longer simply a unit of compute consumption but have become a direct carrier of business value. Xunce's core capability lies in providing vertical AI solutions that act as an "external brain" for general‑purpose large models, ensuring that every token consumed generates a measurable business return. Xunce's solutions are deeply embedded in clients' private clouds and on‑premises systems, acting as a "data hub." Token‑based pricing means the company's revenue is directly tied to clients' AI usage – the more clients use, the more the company earns. Building on this capability, the company is accelerating the evolution of its business model. The results announcement clearly states that Xunce is transitioning from project‑based and subscription models to token‑based pricing, evolving from a traditional tool provider into an "AI Agent enabler." According to the company, token‑based revenue accounted for 5% of total revenue in early 2026, and is expected to reach 20‑30% for the full year. From a financial perspective, this model unlocks three layers of value: first, revenue structure optimization, shifting from one‑time project delivery to recurring service revenue with significantly enhanced predictability; second, improved pricing power, as the company's revenue becomes tied to the value created for clients; and third, expanded profit margins, as project delivery becomes less dependent on headcount, creating room for margin expansion. NVIDIA's "Token Factory Economics" framework is validating this trend at the industry level: competition in the AI inference phase is shifting from "who has more compute" to "who can generate greater business value from each token." Xunce, with its deep expertise in processing high‑quality data across vertical industries, is perfectly positioned at this critical juncture. Strategic Depth: From Asset Management to Robotics and Commercial Aerospace Xunce started in the asset management industry – one of the most demanding sectors in terms of data real‑time requirements and regulatory compliance – where it holds the largest market share, covering the top 10 asset management institutions in China. It was precisely in this high‑concurrency, low‑latency, strong‑consistency environment that Xunce built its full‑stack AI Data Agent technology system, covering everything from data acquisition, cleaning, and standardization to real‑time computation and large model tuning, establishing a core technological moat in millisecond‑level real‑time data processing. In 2025, the company accelerated the replication of this capability across other industries, including telecommunications, power, energy, urban operations, high‑end manufacturing, and healthcare. The share of revenue from non‑asset management businesses increased further from 61.3% in 2024 to 79.6%, reflecting a more diversified business mix. By year‑end, the company had developed over 300 data modules, enabling rapid adaptation to different industry needs through modular combinations and significantly reducing the marginal cost of cross‑industry expansion. More forward‑looking is the company's expansion into two frontier areas: robotics data platforms and commercial aerospace. These scenarios, which demand extreme real‑time performance and reliability, serve both as a testing ground for technical capabilities and as an early entry into high‑growth future markets. In addition, the company plans to steadily advance its global expansion and actively establish strategic partnerships with leading domestic and international compute providers and algorithm companies, building an integrated ecosystem that coordinates compute, algorithms, and data. Valuation Undervaluation: Value Discovery for a Token Stock in Hong Kong In March 2026, Xunce Technology was officially included in the Hang Seng Composite Index. Once it becomes eligible for the Stock Connect program, liquidity is expected to improve significantly. Currently, the company's PS ratio is about 40x, as the token‑based business model accelerates, the company's valuation offers significant room for upside, with the potential to align with large model companies such as Minimax and Zhipu. Against the backdrop of the 15th Five‑Year Plan, which explicitly calls for "building a new form of intelligent economy" and deepening "AI+," demand for real‑time data infrastructure in the AI inference era is only just beginning. Xunce has demonstrated the explosive potential of growth through its revenue doubling, validated the sustainability of its model through its second‑half profitability, and opened up a new valuation narrative in the token economy through its upgrade to token‑based pricing. 27/03/2026 Dissemination of a Financial Press Release, transmitted by EQS News.The issuer is solely responsible for the content of this announcement.Media archive at www.todayir.com
Helen Bryce Appointed BHA’s Legal Counsel for UK Racing
(AsiaGameHub) - The British Horseracing Authority (BHA) has announced the appointment of Helen Bryce as its new General Counsel and Company Secretary, effective from 1 August 2026. This appointment is part of a significant restructuring of the governing body's leadership during a crucial time for UK racing. Bryce will oversee all legal, compliance, risk management, and corporate governance operations, providing counsel to both the Executive and the Board on legal and statutory duties. Her promotion signifies an internal progression, as she joined the BHA in 2017 and currently holds the position of Head of Legal and Governance. Before her tenure at the BHA, Bryce spent ten years at Bird & Bird, where she served as a senior associate in their technology, media, and sport division, developing expertise in intricate regulatory and commercial matters. She succeeds Catherine Beloff, who is leaving the organisation after more than a decade. During her time, Beloff managed two major governance reviews and established an independent judicial panel, contributing to the modernisation of the BHA’s regulatory framework. Bryce expressed that it is a "huge privilege" to join the BHA at a pivotal moment for UK racing. She stated, "The BHA has a critical role to play in safeguarding the integrity and future of British racing. Maintaining the highest standards of corporate governance, legal compliance and transparency is fundamental to that mission. “I look forward to working closely with colleagues and stakeholders across the industry to ensure that our policies and procedures not only meet regulatory expectations but also reinforce trust and accountability across the sport.” BHA heads to negotiation table Her appointment occurs amidst broader executive changes within the BHA. In March, Brant Dunshea officially took on the permanent role of CEO, having previously led the organisation on an interim basis following Julie Harrington's resignation in 2025. Concurrently, the BHA is continuing its search for a new Chair, following the unexpected departure of Lord Charles Allen in February. His six-year term concluded amidst reported disagreements with stakeholders and racing bodies regarding governance direction. The selection of a new Chair is considered vital. The BHA is preparing to enter negotiations with the Department for Culture, Media and Sport (DCMS) and bookmakers, represented by the Betting & Gaming Council (BGC), concerning the future funding model for the horseracing levy. The redesign of the levy was notably excluded from the scope of the UK Gambling Review, a decision that has escalated tensions with bookmakers, some of whom have indicated they might withdraw from racing if terms are unfavourable. Against this backdrop, Bryce's appointment is viewed as a move to bolster the BHA's legal and governance capabilities in anticipation of complex regulatory discussions. Prominent figures, including Matt Hancock, Ben Wallace, and HR veteran Julia Tyson, have already been mentioned as potential candidates for the vacant Chair position. Commenting on the appointment, Dunshea remarked, “Helen has made a valuable contribution to the BHA and to British racing over a sustained period, demonstrating not only astute legal judgement but also a deep understanding of the governance challenges facing modern sport. “At a time when the BHA must engage in complex discussions on funding, regulation and long-term sustainability, her expertise will be central to ensuring that we meet our statutory responsibilities while maintaining the confidence of participants, stakeholders and the public.” He further added, “Her leadership will be instrumental as we navigate a period of structural change for racing, ensuring that our regulatory framework remains robust, transparent and fit for purpose.” This article is provided by a third-party. AsiaGameHub (https://asiagamehub.com/) makes no warranties regarding its content. AsiaGameHub delivers targeted distribution for iGaming, Casino, and eSports, connecting 3,000+ premium Asian media outlets and 80,000+ specialized influencers across ASEAN.
A New Star Wars RPG Merges Gaming Eras 26 Years Later
Bit Reactor/Electronic Arts(SeaPRwire) - Ever since the invention of video games, the medium has constantly served as a space for players to immerse themselves in the fantasy worlds of popular film and television franchises, and many would argue that no large fictional universe has gained more from this trend than Star Wars. Direct adaptations of the core films have had inconsistent results, but the franchise truly flourishes in gaming when developers are given room to craft original stories within a corner of George Lucas’ vast galaxy. Titles like The Force Unleashed, Knights of the Old Republic, and even the recent Jedi: Fallen Order are beloved not just for their Star Wars branding, but because they exist within the universe in a way that feels both familiar and refreshingly new.A huge range of gaming subgenres have gotten the chance to experiment within the Star Wars setting — traditional action-adventure games (Jedi: Fallen Order), dogfighting combat simulators (Star Wars: Rogue Squadron), and even puzzle-focused Lego Star Wars games have all had their turn. But the franchise’s best fit has arguably always been RPGs, which makes perfect sense: in a universe packed with dozens of unique alien species and competing moral and political factions, players naturally want to build a custom character from the ground up. That core philosophy gave us Knights of the Old Republic, one of the greatest Star Wars games and one of the best RPGs ever made. Now, the team at Bit Reactor is putting their own twist on a Star Wars RPG, and from what we’ve heard, they’re delivering a perfect mix of elements pulled from two different eras of the franchise.Star Wars: Zero Company, the upcoming tactical RPG developed by Bit Reactor and published by Electronic Arts, combines the precise, high-risk, high-reward gameplay of the XCOM series with the third-person exploration mechanics of titles like the aforementioned Fallen Order. Bit Reactor founder Greg Foertsch recently spoke to PC Gamer about the project, and clarified that while turn-based combat is the game’s core focus, there is also a massive explorable world outside of battles. “We really wanted to add an element that lets players spend even more time in Star Wars environments, rather than having those spaces limited by what works for fun combat,” he explained.This design choice naturally offers two key benefits. First, blending two rarely combined gameplay styles lets Zero Company appeal beyond just tactical RPG fans, with the hope of winning over adventure game fans as well as anyone who simply wants to explore the Star Wars universe without being tied exclusively to challenging combat. Second, this blend also lets the game — which is set during the Clone Wars era — carry the same sense of wonder and discovery that defined the original Star Wars trilogy.Though set during the Clone Wars, Zero Company does not limit playable characters to only Clone Troopers. | Electronic ArtsGeorge Lucas’ original Star Wars was first and foremost a coming-of-age story that follows the classic Hero’s Journey. Much of what makes it work so well is that as audiences live vicariously through Luke Skywalker, they get to explore worlds completely alien to our own; there is a tangible, meaningful sense of exploration that comes from discovering strange, exciting locations like Cloud City or Dagobah. The prequel trilogy, on the other hand, is far darker and more grounded, focusing on the on-the-ground reality of war and how the conflict served as a stepping stone to undermine democracy.Few games have balanced this line between two eras as confidently as Bit Reactor appears to be doing, which makes Zero Company a very unique entry in the franchise’s huge catalog of video game adaptations. It is exciting that thoughtful, responsive combat and immersive world-building and exploration are just two of the many features players can look forward to when Star Wars: Zero Company finally launches, hopefully in the near future.Star Wars: Zero Company does not currently have an official release date. This article is provided by a third-party content provider. SeaPRwire (https://www.seaprwire.com/) makes no warranties or representations regarding its content. Category: Top News, Daily News SeaPRwire provides global press release distribution services for companies and organizations, covering more than 6,500 media outlets, 86,000 editors and journalists, and over 3.5 million end-user desktop and mobile apps. SeaPRwire supports multilingual press release distribution in English, Japanese, German, Korean, French, Russian, Indonesian, Malay, Vietnamese, Chinese, and more.
















